<SEC-DOCUMENT>0001140361-22-044669.txt : 20221207
<SEC-HEADER>0001140361-22-044669.hdr.sgml : 20221207
<ACCEPTANCE-DATETIME>20221207101859
ACCESSION NUMBER:		0001140361-22-044669
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221205
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221207
DATE AS OF CHANGE:		20221207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0000943452
		STANDARD INDUSTRIAL CLASSIFICATION:	RAILROAD EQUIPMENT [3743]
		IRS NUMBER:				251615902
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	033-90866
		FILM NUMBER:		221449323

	BUSINESS ADDRESS:	
		STREET 1:		30 ISABELLA STREET
		CITY:			PITTSBURGH
		STATE:			PA
		ZIP:			15212
		BUSINESS PHONE:		4128251000

	MAIL ADDRESS:	
		STREET 1:		30 ISABELLA STREET
		CITY:			PITTSBURGH
		STATE:			PA
		ZIP:			15212

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WABTEC CORP
		DATE OF NAME CHANGE:	20000114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WESTINGHOUSE AIR BRAKE CO /DE/
		DATE OF NAME CHANGE:	19950404
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10045145_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:wab="http://wabtec.com/20221205" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Finacial Solutions inc.
         Document created using Broadridge PROfile 22.10.2.5096
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_e5debd7f500b4f519f12a7d42d1fbb75" contextRef="c20221205to20221205" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_e342fe88c58b4c16a6eef6199963f458" contextRef="c20221205to20221205">0000943452</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="wab-20221205.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20221205to20221205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943452</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-05</xbrli:startDate><xbrli:endDate>2022-12-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

      <div style="font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_3fd2021ee04b49aea9ae5191fd393f25" contextRef="c20221205to20221205">8-K</ix:nonNumeric></div>

      <div style="font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

      <div style="font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): December 7, 2022 (<ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_e2e87860617046b78ae53006ac5f0d39" contextRef="c20221205to20221205" format="ixt:date-monthname-day-year-en">December 5, 2022</ix:nonNumeric>)</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
      </div>

      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">


  <tr>

    <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold; font-size: 24pt;">&#160;<ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_b11d91a35dc64fe7bd1c9450c0b8f4f1" contextRef="c20221205to20221205">WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORPORATION</ix:nonNumeric><br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 100.00%;">
                <div style="text-align: center; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.33%; vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_501798fcd172483e9fc6c3e52fc61135" contextRef="c20221205to20221205" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 34%; vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_d5a59d4d309a474090dd6fae08ceb614" contextRef="c20221205to20221205">033-90866</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 33.32%; vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_f33ebe0a75cf4d68872ed939d9c977e8" contextRef="c20221205to20221205">25-1615902</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33.33%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">(State or other jurisdiction of incorporation)</div>
            </td>

    <td style="width: 34%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">(Commission File Number)</div>
            </td>

    <td style="width: 33.32%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_3f47c301fb7b4c53a1492e2c35ec6657" contextRef="c20221205to20221205">30 Isabella Street</ix:nonNumeric><br />
              </div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_67a03bae88204533875e17b7b3870419" contextRef="c20221205to20221205">Pittsburgh</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_7541b58130e64e4ca1c6e8a772b55a1a" contextRef="c20221205to20221205" format="ixt-sec:stateprovnameen">Pennsylvania</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_db6b7ff4a5d54eb19b9a55b6fa54add0" contextRef="c20221205to20221205">15212</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">(Address of principal executive offices)</div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_7048686b9930451997f00c04e6e9321c" contextRef="c20221205to20221205">412</ix:nonNumeric>)
        <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_127f67272bca4be183cee38f8a8c7487" contextRef="c20221205to20221205">825-1000</ix:nonNumeric></div>

      <div style="font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">


  <tr>

    <td style="width: 100%; text-align: center; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0);">Not Applicable</td>

  </tr>

  <tr>

    <td style="width: 100%; text-align: center; font-weight: bold;">(Former name or former address, if changed since last report.)</td>

  </tr>


</table>
        <div><br /></div>

      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
        (<span style="font-family: 'Times New Roman'; font-style: italic;">see</span> General Instruction A.2. below):</div>

      <div style="font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_de39523dde3f4d9a986e2473e8c36b98" contextRef="c20221205to20221205" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_bfd4a6e90ae34489b0cfebdea18f408b" contextRef="c20221205to20221205" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_02c695b5f6f44a27a30a46b48dfb56fa" contextRef="c20221205to20221205" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_99f29e6b20374b7495a483ae2ea099df" contextRef="c20221205to20221205" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 40.35%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Title of each class</div>
            </td>

    <td style="width: 20%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Trading Symbol(s)</div>
            </td>

    <td style="width: 40.41%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 40.35%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_fa81869646b84ceb8620fafd35961c38" contextRef="c20221205to20221205">Common stock, par value $0.01 per share</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_b371d0a19b5f4b62a952d9aebf618bab" contextRef="c20221205to20221205">WAB</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 40.41%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_9b78b14375cf4f32bb7fab435be0738a" contextRef="c20221205to20221205" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric><br />
              </div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter)
        or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

      <div style="font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_a3a869b587fc4edc9f1e73c1be51212f" contextRef="c20221205to20221205" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

      <div style="font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
        financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div style="font-size: 10pt;"><br />
      </div>

      <div style="font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.02</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">Departure of Directors or Certain Executives; Election of Directors; Appointment of Certain Executives; Compensatory Arrangements of Certain Executives.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Westinghouse Air Brake Technologies Corporation (the &#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Company</span></span>&#8221;) entered into Severance and Employment
        Continuation Agreements (each, a <span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Continuation Agreement</span></span> and collectively, the &#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Continuation Agreements</span></span>&#8221;) with the following
        individuals who are the Company&#8217;s named executive officers from its most recent proxy statement (each, an &#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Executive</span></span>&#8221;) effective December 5, 2022:</div>

      <div style="font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; width: 80%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: auto; margin-right: auto;">


  <tr>

    <td style="width: 20%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Rafael Santana</div>
            </td>

    <td style="width: 60%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">President and Chief Executive Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 20%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">John Olin</div>
            </td>

    <td style="width: 60%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Executive Vice President and Chief Financial Officer<br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 20%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">David DeNinno</div>
            </td>

    <td style="width: 60%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Executive Vice President, General Counsel and Secretary</div>
            </td>

  </tr>

  <tr>

    <td style="width: 20%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Pascal Schweitzer</div>
            </td>

    <td style="width: 60%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">President, Freight Services Group</div>
            </td>

  </tr>

  <tr>

    <td style="width: 20%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Eric Gebhardt</div>
            </td>

    <td style="width: 60%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Executive Vice President and Chief Technology Officer</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Each of Messrs. Santana, Olin, and DeNinno previously entered into a Continuation Agreement with the Company providing for potential severance payments for termination of
        employment in connection with a change in control of the Company.&#160; In addition, Mr. Santana entered into a Severance Agreement with the Company dated May 6, 2020, providing for potential severance payments for termination of employment other than
        in connection with a change in control of the Company.&#160; The new Continuation Agreements supersede and replace in their entirety these prior agreements. The severance payments and benefits under the Continuation Agreements will also be in lieu of
        any severance payments and benefits under any severance plans of the Company, provided that any more favorable equity vesting provisions included in award agreements will control.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Continuation Agreements, which have an indefinite term, provide that each Executive will receive severance payments and certain benefits in the event of the
        Executive&#8217;s termination by the Company without cause (as defined in the Continuation Agreements) or by the Executive for good reason (as defined in the Continuation Agreements). The severance payments and benefits payable to each Executive upon
        such termination of employment will vary based on whether or not the termination of employment occurs during the period from the date of a change in control (as defined in the Continuation Agreements) through the second anniversary of such date
        (the &#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Change in Control Period</span></span>&#8221;).</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If such termination of employment does not occur during a Change in Control Period, the severance payments and benefits will be as follows:</div>

      <div style="font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">a lump sum cash severance payment equal to: (A) for Mr. Santana, two times the sum of his base salary and target annual bonus; and (B) for each of the other Executives, the sum of (1) the
                Executive&#8217;s base salary plus 1/52 of the Executive&#8217;s base salary for each full year of the Executive&#8217;s service with the Company and (2) the Executive&#8217;s target annual bonus; provided that the amount in clause (1) will not exceed one and
                one-half times the Executive&#8217;s base salary (the &#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Cash Severance Payment</span></span>&#8221;);</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">a lump sum payment equal to: (A) for Mr. Santana, twenty-four times the full monthly premium cost to the Company of group medical, dental, vision, life, and long-term disability coverage for Mr.
                Santana; and (B)&#160;&#160; for each of the other Executives, the Company&#8217;s portion of the monthly premium cost of the Executive&#8217;s medical, dental and vision coverage multiplied by the number of full months of base salary that is represented by the
                base salary in the Severance Payment described above (the &#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Benefits Payment</span></span>&#8221;);</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">a pro rata portion of the Executive&#8217;s annual bonus for the year in which the termination date occurs based on actual performance of the Company and the number of days the Executive is employed
                during such year, payable at the same time and on the same terms as annual bonuses paid to other executives of the Company (the &#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Pro-Rated Annual Bonus</span></span>&#8221;);</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">a lump sum payment equal to: (A) $100,000 for Mr. Santana; and (B) $50,000 for each of the other Executives, for transition cost assistance (the &#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Transition


                    Payment</span></span>&#8221;); and</div>
            </td>

  </tr>


</table>
      <div> <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">certain minimum equity vesting requirements as follows: for Mr. Santana, full vesting, and for each of the other Executives, pro rata vesting (based on the portion of the vesting period that has
                elapsed as of the termination date of all Post-2021 Equity Grants (as defined in the Continuation Agreements)), subject to actual performance results for the full performance period for any awards with performance-based vesting conditions,
                and provided that any such vested grants that are options or stock appreciation rights will remain exercisable for three years or until the end of the applicable term, if earlier.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If such termination of employment occurs during a Change in Control Period, the severance payments and benefits will be similar to those described above but in some cases
        in larger amounts, as follows:</div>

      <div style="font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Cash Severance Payment will be equal to the sum of the Executive&#8217;s base salary and target annual bonus multiplied by (A) for Mr. Santana, three; and (B) for each of the other Executives, two;</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Benefits Payment will be equal to the applicable monthly benefits cost described above multiplied by (A) for Mr. Santana, thirty-six; and (B) for each of the other Executives, twenty-four;</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Pro-Rated Annual Bonus;</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Transition Payment; and</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the minimum equity vesting provisions described above for Post-2021 Equity Grants, except the vesting for both Mr. Santana and the other Executives will be full, rather than prorated,
                performance-vesting awards will have performance goals deemed achieved at maximum levels, and the awards in all cases will be subject to the provisions of the Company&#8217;s Stock Incentive Plan regarding treatment of awards upon a change in
                control of the Company (i.e., depending on whether awards are assumed or replaced by the buyer in the transaction).</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The severance payments and benefits are conditioned on the Executive signing and not revoking a general release of claims.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In the event of any termination of employment, the Executive will receive any earned and unpaid base salary through the date of termination, any unpaid annual incentive
        bonus payable with respect to a prior fiscal year, any unpaid reimbursements due to the Executive, any accrued but unused personal time off days, and any vested and non-forfeitable employee benefits payable under the terms and conditions of the
        applicable plan or award agreement (the &#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Accrued Obligations</span></span>&#8221;).&#160; If, at any time, the Executive&#8217;s employment is terminated by the Company for cause, due to death or disability, or by the
        Executive&#8217;s voluntary resignation other than for good reason, the Executive will receive only the Accrued Obligations, except that in case of termination due to death or disability, the Executive will also receive the Pro-Rated Annual Bonus and
        full vesting of equity awards (subject to performance results for any performance-vesting awards).</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Any amounts paid to an Executive under a Continuation Agreement will be reduced to the maximum amount that can be paid without being considered an excess parachute
        payment under Internal Revenue Code Section 280G and subject to the excise tax under Internal Revenue Code Section 4999, but only if the net after-tax benefit of the reduced amount to the Executive is higher than the net after-tax benefit of the
        unreduced amount.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Mr. Santana&#8217;s Continuation Agreement also specifies that his annual base salary will not be less than $1,250,000 and that his target annual bonus will not be less than
        160% of his base salary.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Continuation Agreements contain restrictive covenants, including non-competition and non-solicitation covenants during the Executive&#8217;s employment and for the one-year
        period following the Executive&#8217;s termination date, and confidentiality and non-disparagement covenants.</div>

      <div style="font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing summary of the Continuation Agreements does not purport to be complete and is qualified in its entirety by reference to the Continuation Agreements. A copy
        of the form of Continuation Agreement for Mr. Santana is attached as Exhibit 10.1 to this Current Report on Form 8-K, and a copy of the form of Continuation Agreement for the other Executives is attached as Exhibit 10.2 to this Current Report on
        Form 8-K.&#160; The terms of such Continuation Agreements are incorporated herein by reference.</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(d) Exhibits</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br />
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 12.06%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;"><span style="text-decoration: underline;">Exhibit No.</span></div>
            </td>

    <td style="width: 87.94%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;"><span style="text-decoration: underline;">Description</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 12.06%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 87.94%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 12.06%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><a href="brhc10045145_ex10-1.htm">10.1</a></div>
            </td>

    <td style="width: 87.94%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Form of Continuation Agreement for Rafael Santana</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12.06%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><a href="brhc10045145_ex10-2.htm">10.2</a></div>
            </td>

    <td style="width: 87.94%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Form of Continuation Agreement for Executives other than Rafael Santana</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

      <div style="font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
        undersigned hereunto duly authorized.</div>

      <div style="font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Date: December 7, 2022</div>
            </td>

    <td colspan="3" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">WESTINGHOUSE AIR BRAKE</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br />
            </td>

    <td colspan="3" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">TECHNOLOGIES CORPORATION</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br />
            </td>

    <td colspan="3" style="vertical-align: top; font-size: 10pt;"><br />
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;"><br />
            </td>

    <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>

    <td colspan="2" style="vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">&#160;/s/ David L. DeNinno </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br />
            </td>

    <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
            </td>

    <td style="width: 42%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">David L. DeNinno</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br />
            </td>

    <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title:</div>
            </td>

    <td style="width: 42%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Executive Vice President and General Counsel</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br />
      </div>

      <div style="font-size: 10pt;"><br />
      </div>

      <div style="font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    </div>

  </div>

  <div><span style="font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>brhc10045145_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solution Inc.
         Document created using Broadridge PROfile 22.10.2.5096
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 10.1</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SEVERANCE AND EMPLOYMENT CONTINUATION AGREEMENT</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">THIS SEVERANCE AND EMPLOYMENT CONTINUATION AGREEMENT (this "Agreement") is entered into on December 5, 2022 (the "Effective Date") by and between
        Westinghouse Air Brake Technologies Corporation, a Delaware corporation (the "Company") and Rafael Santana (the "Executive") (each referred to herein as a "Party", and, collectively, the "Parties").</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, the Parties are subject to an Employment Continuation Agreement, dated as of May 6, 2020 (the "Prior ECA"), and a Severance Agreement,
        dated as of May 6, 2020 (the &#8220;Prior SA,&#8221; and together with the Prior ECA, the &#8220;Prior Agreements&#8221;).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, effective as of the Effective Date, this Agreement replaces and supersedes all previous agreements between the Executive and the Company
        concerning the subject matter herein, including without limitation, the Prior Agreements.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, in consideration of the premises and of the mutual promises and covenants contained herein, the Company and the Executive, intending
        to be legally bound, hereby agree as follows:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Definitions</u></font>.&#160; For purposes of this Agreement, the terms listed in this Section 1 have the meanings set forth herein.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Accrued Obligations</u></font>. "Accrued Obligations" shall mean (i) any Base Salary earned through the Executive's termination of employment that remains unpaid; (ii) any annual incentive bonus payable with respect to any fiscal
            year which ended prior to the effective date of the Executive's termination of employment, which remains unpaid; (iii) any accrued but unused personal time off days; (iv) any unpaid reimbursement due to the Executive on or prior to the date of
            such termination of employment under the Company's expense reimbursement policy; and (v) any vested and non-forfeitable employee benefits to which Executive is entitled upon termination of the Executive's employment with the Company in
            accordance with the terms and conditions of any applicable plan or award agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Act.</u></font>&#160; "Act" shall mean the Securities Exchange Act of 1934, as amended.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Base Salary</u></font>.&#160; "Base Salary" shall have the meaning set forth in Section 4(a).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Board</u></font>.&#160;&#160; "Board" shall mean the Board of Directors of the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Cause</u></font>.&#160; "Cause" shall mean any of the following grounds for the Executive's termination of employment: (i) conviction of, or plea of nolo contendere to, a felony or a crime involving moral turpitude; (ii) a willful act
            or acts of dishonesty or gross misconduct which results or is intended to result in material damage to the Company's business or reputation; (iii) any willful and material violation of Company insider trading policies, any Company written
            employment policies, or the Company's code of conduct; or (iv) willful and continued refusal to substantially perform the required duties with the Company (other than any such refusal resulting from incapacity due to physical or mental illness
            or Disability or any actual or anticipated refusal after a termination for Good Reason) after a written demand for substantial performance is delivered to Executive by the Board, which demand specifically identifies the manner in which the
            Board believes that Executive has not substantially performed the required duties.&#160; For purposes of determining &#8220;Cause,&#8221; no act or omission by the Executive shall be considered &#8220;willful&#8221; unless it is done or omitted in bad faith or without
            reasonable belief that the Executive&#8217;s action or omission was in the best interests of the Company. Any act or failure to act based upon: (A) authority given pursuant to a resolution duly adopted by the Board or any other direction from the
            Board or (B) advice of counsel for the Company, shall be conclusively presumed to be done or omitted to be done by the Executive in good faith and in the best interests of the Company. For the avoidance of doubt, poor performance (including
            failure to meet strategic goals or business plan) shall not be a basis for a Cause termination. The Executive may only be terminated for Cause by a resolution duly adopted by the Board and approved by a majority of the Board members (excluding
            Executive) after Executive has been given a reasonable opportunity to be heard before the Board with his counsel present.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Change in Control</u></font>.&#160;&#160; A "Change in Control" shall mean the date upon which any of the following events occur:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Any Person (as that term is used
            in Sections 13(d) and 14(d) of the Act), other than the Company, a subsidiary, or any employee benefit plan(s) sponsored by the Company or a subsidiary, has acquired the Beneficial Ownership (as determined under Rule 13d-3 under the Act),
            directly or indirectly, of securities of the Company entitling such Person to 30% or more of the Voting Power of the Company;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">At any time less than 51% of the
            members of the Board (excluding vacant seats) shall be Continuing Directors; or</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The consummation of a merger,
            consolidation, share exchange, division or sale or other disposition of assets of the Company as a result of which the stockholders of the Company immediately prior to such transaction shall not hold, directly or indirectly, immediately
            following such transaction a majority of the Voting Power, and in substantially the same proportions as they held prior to such transaction, of (A) in the case of a merger or consolidation, the surviving or resulting corporation, (B) in the
            case of a share exchange, the acquiring corporation or (C) in the case of a division or a sale or other disposition of assets, each surviving, resulting or acquiring corporation which, immediately following the transaction, holds more than 30%
            of the consolidated assets of the Company immediately prior to the transaction.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the foregoing, if required in order to comply with section 409A of the Code, then for purposes of payment of any amount upon the Change in Control, no
        Change in Control shall be deemed to have occurred upon an event described in items (i) - (iii) above unless the event would also constitute a change in ownership or effective control of, or a change in the ownership of a substantial portion of the
        assets of, the Company under section 409A of the Code.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Change in Control Period</u></font>. "Change in Control Period" shall mean the period commencing on the effective date of a Change in Control and ending on the second anniversary of such Change in Control.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160;&#160; <u></u><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>CIC Termination</u></font>. "CIC Termination" shall mean termination of the Executive's employment by the Company without Cause or by the Executive for Good Reason during the Change in Control Period.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Code</u></font>. "Code" shall mean the Internal Revenue Code of 1986, as amended.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Committee.</u></font> "Committee" shall mean the Compensation Committee of the Board or its delegate designated consistent with applicable law.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Continuing Directors</u></font>. "Continuing Directors" shall mean a director of the Company who either (a) was a director of the Company on the Effective Date or (b) is an individual whose election, or nomination for election, as
            a director of the Company was approved by a vote of at least two-thirds of the directors then still in office who were Continuing Directors (other than an individual whose initial assumption of office is in connection with an actual or
            threatened election contest relating to the election of directors of the Company which would be subject to Rule 14a-11 under the Act, or any successor rule).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(l)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Disability</u></font>. "Disability" shall have the meaning as set forth in section 409A(a)(2)(C) of the Code.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(m)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Good Reason</u></font>. "Good Reason" shall mean the occurrence of one or more of the following, without the Executive's consent:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">A material diminution in, or an assignment materially inconsistent with, the Executive&#8217;s position, title, authority, duties, or responsibilities, or a change in the Executive&#8217;s reporting line such that the Executive no longer reports
            solely and directly to the Company&#8217;s Board of Directors;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Any failure by the Company to nominate the Executive for election as a director of the Company during the Term;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">A material reduction in the Executive's Base Salary or annual incentive compensation opportunity;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">During a Change in Control Period, a material reduction in the Executive&#8217;s total direct compensation (at target) from the Executive&#8217;s total direct compensation (at target) for the
              last full year preceding the Change in Control, which</font>&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">total direct compensation (at target) for the Executive is comprised of Base Salary, annual incentive compensation
              opportunity (at target performance), and the aggregate target grant date value of equity awards granted to the Executive under the Company&#8217;s long-term incentive compensation program for key executives with respect to the applicable year;</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">A material breach by the Company
            with any material provision of this Agreement or any other material written agreement between the Company and the Executive;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"> Change in the geographic location
            of the Executive's offices of more than thirty-five (35) miles from the location of such offices immediately prior to the relocation, or, during a Change in Control Period, the Company requiring that the Executive travel on Company business to
            a substantially greater extent than required immediately prior to the Change in Control; or</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Failure of the Company to obtain
            assumption of this Agreement by a successor entity.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Executive must provide written notice of termination of employment for Good Reason to the Company within sixty (60) days after the event constituting Good Reason
        first occurs, which notice shall state such Good Reason in reasonable detail.&#160; The Company shall have a period of thirty (30) days in which it may correct the act or failure to act that constitutes the grounds for Good Reason as set forth in the
        Executive's notice of termination of employment.&#160; If the Company does not correct the act or failure to act, the Executive must terminate the Executive's employment for Good Reason within sixty (60) days after the end of the cure period, in order
        for the termination of employment to be considered a Good Reason <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">termination of employment.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(n)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Monthly Benefits Costs</u>. "Monthly Benefits Costs" shall mean an amount equal to the full monthly premium cost of the health (including hospitalization, medical, dental, and vision), life, and long-term
              disability insurance coverage applicable to the Executive as of the date of Executive's termination of employment.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(o)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Pro-Rated Annual Bonus</u></font>. "Pro-Rated Annual Bonus" shall mean the annual bonus amount the Executive would be entitled to receive for the fiscal year in which the Executive&#8217;s employment terminates, based on the actual
            achievement of the applicable Company performance goals for such year (and with any subjective goals treated as achieved at not less than target, and without the application of any negative discretion by the Board) as determined as of the end
            of the fiscal year, prorated based on the number of days Executive was employed during the fiscal year of Executive&#8217;s termination, paid at the same time as the Company pays annual bonuses for such fiscal year to other executives.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(p)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Release</u></font>. "Release" shall mean a written release of any and all claims against the Company and its affiliates, with respect to all matters arising out of the Executive's employment with the Company, substantially in the
            form attached hereto as <font style="font-family: 'Times New Roman';"><u>Exhibit A</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(q)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Subsidiary</u></font>. "Subsidiary" shall mean any corporation in an unbroken chain of corporations beginning with the Company, if each of the corporations other than the last corporation in the unbroken chain owns stock
            possessing at least fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in the chain.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(r)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Target Annual Bonus</u></font>.&#160; "Target Annual Bonus" shall have the meaning set forth in Section 4(b).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(s)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Voting Power</u></font>. "Voting Power" shall mean such number of the Voting Shares as shall enable the holders thereof to cast such percentage of all the votes which could be cast in an annual election of directors (without
            consideration of the rights of any class of stock other than the common stock of the Company to elect directors by a separate class vote).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(t)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Voting Shares</u></font>.&#160; "Voting Shares" shall mean all securities of the Company entitling the holders thereof to vote in an annual election of directors (without consideration of the rights of any class of stock other than the
            common stock of the Company to elect directors by a separate class vote).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Term</u></font>.&#160; This Agreement shall commence on the Effective Date and shall continue until terminated pursuant to the terms of this Agreement (the "Term").</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Position and Duties</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">During the Term, the Executive shall
            continue to serve as the Company&#8217;s Chief Executive Officer and President, and shall perform such duties commensurate with his positions as are reasonably required by the Board, to which Executive will solely and directly report.&#160; In the
            position of Chief Executive Officer and President, Executive shall have the responsibilities, duties and authority of a person in a similar position at a similarly-sized public company, and such other duties, authorities and responsibilities
            that are not inconsistent with Executive&#8217;s position as assigned from time to time by the Board.&#160; During the Employment Period, Executive shall, without compensation other than that herein provided, also serve and continue to serve, if and when
            elected and re-elected, as a member of the Board.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">During the Term,
            Executive agrees to devote substantially all of his business time and attention to the business and affairs of the Company and the good faith performance of&#160; the responsibilities assigned to the Executive hereunder, to the extent necessary to
            discharge such responsibilities, except for (i) time spent in managing personal, financial and legal affairs and serving on corporate, civic or charitable boards or committees, in each case only if and to the extent not substantially
            interfering with the performance of such responsibilities, and (ii) periods of vacation and sick leave to which the Executive is entitled. It is expressly understood and agreed that the Executive's continuing to serve on any boards and
            committees on which the Executive is serving or with which the Executive is otherwise associated immediately preceding the Effective Date shall not be deemed to interfere with the performance of the Executive's services to the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Compensation and Benefits</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Base Salary</u></font>. During the Term, the Company agrees to pay Executive a base salary of not less than $1,250,000 per year, payable in installments based on the Company's regular payroll practices as may be in effect from
            time to time. The Committee shall review Executive&#8217;s base salary annually for increase (but not decrease), and the annual base salary, as increased from time to time, shall constitute the &#8220;Base Salary&#8221; for purposes of this Agreement.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Annual Bonus</u></font>. During the Term, Executive will be eligible to participate in the Wabtec Executive Bonus Plan or its successor and will have a target annual incentive bonus amount (measured at the target level, identified
            "goal" target or other similar target, without taking into account any incentive override for above goal performance, or any project-specific or other non-standard incentives) (the &#8220;Target Annual Bonus&#8221;) equal to no less than 160% of the Base
            Salary.&#160; The Committee shall review Executive&#8217;s Target Annual Bonus annually for increase (but not decrease), and the target annual incentive bonus amount, as increased from time to time, shall constitute the &#8220;Target Annual Bonus&#8221; for purposes
            of this Agreement.&#160; Executive&#8217;s actual annual bonus for the applicable year pursuant to this Section 4(b) shall be based on the achievement of specified performance goals as established and determined by the Compensation Committee of the Board
            of Directors of the Company following consultation with Executive. Any annual bonus paid to Executive in accordance with the Wabtec Executive Bonus Plan and in any event within 2&#189; months following the year for which the bonus is earned, in
            accordance with the Company's standard payroll practices, unless electively deferred by the Executive pursuant to any deferral programs or arrangements that the Company may make available to the Executive.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Long-Term Incentive Compensation Programs</u>. During the Term, Executive shall participate in all long-term incentive compensation programs for key executives, including stock option or stock incentive plans,
              at a level commensurate with Executive&#8217;s position and on terms and conditions that are no less favorable than the terms and conditions applicable to other similarly situated senior executive officers of the Company, except as otherwise
              expressly provided in this Agreement</font>. </font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Benefit Plans</u>.&#160; During the Term, Executive (and, to the extent applicable, Executive's dependents) shall be entitled to participate in or be covered under all pension, retirement, deferred compensation,
              savings, medical, dental, health, disability, group life, accidental death and travel accident insurance plans and programs of the Company and its affiliated companies at a level that is commensurate with the level generally applicable to
              similarly situated officers, subject to the terms and conditions of the applicable plans. </font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Expenses</u>. During the Term, the Executive shall be entitled to receive prompt reimbursement for all reasonable expenses incurred by the Executive in accordance with the policies and procedures of the
              Company as in effect from time to time. In no event, however, will any expense which is incurred in a particular year be reimbursed later than the end of the Executive's taxable year following the taxable year in which the expense was
              incurred. The amount of reimbursable expenses incurred in one taxable year by the Executive shall not affect the amount of reimbursable expenses in a different taxable year, and such reimbursement shall not be subject to liquidation or
              exchange for another benefit.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Vacation and Fringe Benefits</u></font>. During the Term, the Executive shall be entitled to paid vacation and fringe benefits at a level that is commensurate with the paid vacation and fringe benefits available to the
            Executive immediately prior to the Effective Date, or, if more favorable to the Executive, at the level made available to the Executive or other similarly situated officers at any time thereafter.&#160; Executive shall have use of the Company&#8217;s
            NetJets (or similar) arrangement for business travel for so long as such arrangement is in place and subject to Company policy.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Indemnification</u>. During and after the Term, the Company shall indemnify the Executive and hold the Executive harmless from and against any claim, loss or cause of action arising from or out of the
              Executive's performance as an officer, director or employee of the Company or any of its subsidiaries or in any other capacity, including any fiduciary capacity, in which the Executive serves at the request of the Company to the maximum
              extent permitted by applicable law and the Company's Certificate of Incorporation and By-laws (the "Governing Documents") and the Company shall maintain existing or comparable policies of insurance covering such matters, provided that in no
              event shall the protection afforded to the Executive hereunder be less than that afforded under the Governing Documents as in effect immediately prior to the Effective Date.</font></font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Office and Support Staff</u>. The Executive shall be entitled to an office with furnishings and other appointments, and to secretarial and other assistance, at a level that is at least commensurate with the
              foregoing provided to other similarly situated officers provided that such items shall be at least equivalent to those provided to the Executive immediately prior to the Effective Date.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Termination of Employment Without Cause or Resignation for Good Reason</u></font>.&#160; The Company may terminate the Executive's employment with the Company at any time without Cause upon not less than thirty (30) days' prior written
            notice to the Executive, and the Executive may resign for Good Reason in accordance with the procedural requirements set forth in the definition thereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Payment and Benefits Upon a Termination of Employment Without Cause or Resignation for Good Reason Other than During a Change in Control Period</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">If the Executive's employment is
            terminated by the Company without Cause or by the Executive for Good Reason, other than during a Change in Control Period, if the Executive executes and does not revoke the Release in accordance with Section 6(b), and so long as the Executive
            continues to comply in all material respects with the provisions of Section 12 below, in addition to the Accrued Obligations, then the Executive shall be entitled to receive the following:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">On the 61st day following the
            date of termination, a lump sum payment equal to the product of (A) two (2) times (B) the sum of (x) the Executive&#8217;s Base Salary plus (y) the Executive&#8217;s Target Annual Bonus (in each such case at the level in effect on the date of termination,
            disregarding any reduction which constitutes Good Reason);</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">On the 61st day following the date of termination, a lump sum payment equal to the product of (A) twenty four (24) times (B) the Monthly Benefits Cost;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Payment of a </font>Prorated Annual Bonus;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">On the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day following
            the date of termination, payment of a lump sum amount of $100,000 to defray transition costs; and</font></font> <br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Effective as of the date of
            termination, each outstanding equity award that was granted to the Executive on or after January 1, 2022 and is held by the Executive immediately prior to the date of termination (each, a "Post-2021 Equity Grant") shall be treated in accordance
            with the following terms, except to the extent that the applicable award agreement provides better treatment for the Executive: (A) each Post-2021 Equity Grant which vests based upon the Executive&#8217;s continued service over time shall become
            fully vested and/or exercisable, as the case may be, and shall be paid according to the terms of the grant agreement; (B) each Post-2021 Equity Grant which vests based upon attainment of performance criteria shall remain outstanding and shall
            vest (or be forfeited) and be paid based on the actual performance achieved for the applicable performance period pursuant to the terms and conditions of the agreement evidencing such performance-based award; and (C) after giving effect to
            clauses (A) and (B), the vested portion of each Post-2021 Equity Grant that is a stock option or stock appreciation right shall be exercisable until the earlier of (x) the expiration date of such stock option or stock appreciation right under
            the grant agreement or (y) the third anniversary of the date of termination; </font></font></div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div style="text-align: justify;">provided, however, that the payment dates set forth in this Section 6(a) shall be subject to the requirements set forth in Section 19(h) in all respects.<font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> </font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Outstanding equity awards that were granted to the Executive prior to January 1, 2022 shall vest and be treated in accordance with the terms of the applicable award
        agreements.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Release</u></font>. Notwithstanding anything herein to the contrary, the Company shall not be obligated to make any payment under Section 6(a) of this Agreement unless (i) prior to the 60th day following the Executive's date of
            termination (or such other date as may be required by law), Executive executes a Release, and (ii) any applicable revocation period has expired during such 60-day period without Executive revoking such Release.&#160; If the Executive does not sign,
            or the Executive revokes, the Release, no other payments or benefits shall be due under this Agreement to the Executive other than the Accrued Obligations.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Death and Disability</u></font>.&#160; If the Executive's employment is terminated by reason of the Executive's death or Disability, then the Executive, or the Executive's estate, as applicable, shall be entitled to receive payment of
            the Accrued Obligations and a Pro-Rated Annual Bonus, payable at the same time and on the same terms as annual bonuses for the year of the Executive's termination are paid to other executives of the Company, but in any event no later than March
            15 of the calendar year following the calendar year in which the Executive's termination of employment occurs.&#160; Outstanding equity awards shall be subject to the terms of the applicable award agreements; provided, however, that vesting
            treatment upon termination of employment for death or Disability shall be no less favorable to the Executive as provided in Section 6(a)(v) above (regarding termination of employment without Cause or with Good Reason).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">8.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Cause</u></font>.&#160; The Company may terminate the Executive's employment at any time for Cause, in which event the Executive shall be entitled to receive payment of the Accrued Obligations. Outstanding equity awards shall be
            subject to the terms of the applicable award agreements.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">9.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Voluntary Termination other than for Good Reason</u></font>. The Executive may, upon not less than thirty (30) days' written notice to the Company, voluntarily terminate his or her employment for any reason other than Good Reason,
            in which event the Executive shall be entitled to receive payment of the Accrued Obligations.<font style="font-family: 'Times New Roman'; font-weight: bold;">&#160; </font>Outstanding equity awards shall be subject to the terms of the applicable
            award agreements, <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">subject to continuation and/or acceleration of vesting in connection with Executive&#8217;s retirement (as defined therein) under the Company&#8217;s retirement policy as
              in effect from time to time and consistent with past practice (and on terms no less favorable than those in effect prior to the Effective Date).</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Payment and Benefits Upon a CIC Termination</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>CIC Termination</u></font>.&#160; Notwithstanding anything to the contrary herein, if a CIC Termination occurs, if the Executive executes and does not revoke the Release in accordance with Section 10(b), and so long as the Executive
            continues to comply in all material respects with the provisions of Section 12 below, in addition to the Accrued Obligations, the Executive shall be entitled to receive the following:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160; On the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day following
            the date of the CIC Termination <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(or if later, following the date of the Change in Control)</font>, a single lump sum payment of an amount equal to (A) three (3) times (B) the
            sum of (x) the Executive's Base Salary (at the level in effect on the date of termination, disregarding any reduction which constitutes Good Reason or was made within six months prior to termination) plus (y) Executive's Target Annual Bonus (at
            the level in effect on the date of termination and disregarding any reduction which constitutes Good Reason or was made within six months prior to termination of employment);</font></font></div>
      <div style="font-size: 10pt; text-indent: 108pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(ii)</font><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>On the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day following the date of the CIC Termination <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(or if later, following the date of the
              Change in Control)</font>, a lump sum payment equal to the Monthly Benefits Cost multiplied by thirty-six (36);</font></font></div>
      <div style="font-size: 10pt; text-indent: 108pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(iii)</font><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160; Payment of a Prorated Annual Bonus
            at the same time and on the same terms as annual bonuses for the year of the Executive's termination are paid to other executives of the Company, but in any event no later than March 15 of the calendar year following the calendar year in which
            the Executive's termination of employment occurs;</font></font></div>
      <div style="font-size: 10pt; text-indent: 108pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(iv)</font><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160; On the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day following
            the date of the CIC Termination <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(or if later, following</font><font style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">&#160;</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the date of the Change in Control)</font>, payment of a lump sum amount of $100,000 to defray transition costs; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Effective as of the date of the CIC
            Termination and except to the extent that the applicable award agreement provides better treatment for the Executive, (A) all Post-2021 Equity Grants held by the Executive immediately prior to the CIC Termination which vest based upon the
            Executive's continued service over time shall accelerate, become fully vested and/or exercisable, as the case may be, as of the date of the CIC Termination, and shall be paid according to the terms of the grant agreement, (B) all Post-2021
            Equity Grants held by the Executive immediately prior to the CIC Termination which vest based upon attainment of performance criteria shall become immediately vested assuming maximum performance results and shall be paid according to the terms
            of the applicable award agreement, and (C) each Post-2021 Equity Grant that is a stock option or stock appreciation right held by the Executive shall be exercisable until the earlier of (x) the expiration date of such stock option or stock
            appreciation right under the grant agreement or (y) the third anniversary of the date of termination;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Provided, however, that the payment dates set forth in Section 10(a) shall be subject to the requirements set forth in Section 19(h) in all respects. Outstanding
        equity awards that were granted to the Executive prior to January 1, 2022 shall be subject to the terms of the applicable award agreements.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Release</u></font>. Notwithstanding anything herein to the contrary, the Company shall not be obligated to make any payment under Section 10(a) of this Agreement unless (i) prior to the 60th day following the Executive's date of
            termination (or such other date as may be required by law), the Executive executes a Release, and (ii) any applicable revocation period has expired during such 60-day period without the Executive revoking such Release. If the Executive does not
            sign, or the Executive revokes, the Release, no other payments or benefits shall be due under this Agreement to the Executive other than the Accrued Obligations.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">11.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Section 280G</u></font>.&#160; In the event of a change in ownership or control under section 280G of the Code, if it shall be determined that any payment or distribution in the nature of compensation (within the meaning of section
            280G(b)(2) of the Code) to or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise (a "Payment"), would constitute an "excess parachute payment" within
            the meaning of section 280G of the Code, the aggregate present value of the Payments under the Agreement shall be reduced (but not below zero) to the Reduced Amount (defined below) if and only if the Accounting Firm (described below) determines
            that the reduction will provide the Executive with a greater net after-tax benefit than would no reduction.&#160; No reduction shall be made unless the reduction would provide Executive with a greater net after-tax benefit.&#160; The determinations under
            this Section shall be made as follows:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The "Reduced Amount" shall be an
            amount expressed in present value which maximizes the aggregate present value of Payments under this Agreement without causing any Payment under this Agreement to be subject to the Excise Tax (defined below), determined in accordance with
            section 280G(d)(4) of the Code.&#160; The term "Excise Tax" means the excise tax imposed under section 4999 of the Code, together with any interest or penalties imposed with respect to such excise tax.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Payments under this Agreement shall
            be reduced on a nondiscretionary basis in such a way as to minimize the reduction in the economic value deliverable to the Executive. Where more than one payment has the same value for this purpose and they are payable at different times, they
            will be reduced on a pro rata basis.&#160; Only amounts payable under this Agreement shall be reduced pursuant to this Section.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">All determinations to be made under
            this Section shall be made by an independent nationally recognized accounting firm or compensation consultant selected by the Company and agreed to by the Executive immediately prior to the change-in-ownership or -control transaction (the
            "Accounting Firm").&#160; The Accounting Firm shall provide its determinations and any supporting calculations both to the Company and the Executive within 10 days of the transaction.&#160; Any such determination by the Accounting Firm shall be binding
            upon the Company and the Executive.&#160; The Company and the Executive shall cooperate in case of a potential change in ownership or control of the Company to in good faith consider alternatives to mitigate any Section 280G exposure, including the
            valuation of any noncompetition covenants and/or acceleration of incentive compensation, although the Company cannot guaranty any such alternative arrangements&#160; will be available or approved by the Company and neither the Executive nor the
            Company shall be obligated to enter into any such arrangements. All of the fees and expenses of the Accounting Firm in performing the determinations referred to in this Section shall be borne solely by the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">12.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Restrictive Covenants</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Confidential Information</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Executive shall hold in a
            fiduciary capacity for the benefit of the Company all secret or confidential information, knowledge or data relating to the Company or any of its affiliated companies, and their respective businesses, (A) obtained by the Executive during the
            Executive's employment by the Company or any of its affiliated companies and (B) not otherwise public knowledge (other than by reason of an unauthorized act by the Executive). After termination of the Executive's employment with the Company,
            the Executive shall not, without the prior written consent of the Company, unless compelled pursuant to an order of a court or other body having jurisdiction over such matter, communicate or divulge any such information, knowledge or data to
            anyone other than the Company and those designated by it. The foregoing shall not apply to information that (1) was known to the public prior to its disclosure to Executive; (2) becomes generally known to the public or within the Company&#8217;s
            industry subsequent to disclosure to Executive through no wrongful act of Executive or any representative of Executive; (3) <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">is disclosed by Executive in the good faith
              performance of his duties hereunder; or </font>(4) Executive is required to disclose by applicable law, regulation or legal process or in connection with any dispute with the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';">No Company policy or individual
            agreement between the Company and the Executive (including this Agreement) shall prevent the Executive from providing, without prior notice to the Company, information to government authorities regarding possible legal violations, participating
            in investigations, testifying in proceedings regarding the Company's past or future conduct, engaging in any future activities protected under the whistleblower statutes administered by any government agency (e.g., EEOC, NLRB, SEC, etc.) or
            receiving a monetary award from a government-administered whistleblower award program for providing information directly to a government agency.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The U.S. Defend Trade Secrets Act
            of 2016 ("DTSA") provides that an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (A) is made in confidence to a federal, state, or local government
            official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such
            filing is made under seal. In addition, the DTSA provides that an individual who files a lawsuit for retaliation for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret
            information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Non-Competition and Non-Solicitation</u></font>. See <font style="font-family: 'Times New Roman';"><u>Exhibit B</u></font> for the applicable non-competition and non-solicitation provisions.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Non-Disparagement</u>.&#160; The Executive shall not disparage the Company and its subsidiaries or their respective officers, directors, employees and, in their capacity as such, their significant institutional
              investors, or make any public statement reflecting negatively on the Company or its subsidiaries or their respective officers, directors, employees, and in their capacity as such, their significant institutional investors, including (without
              limitation) any matters relating to the operation or management of the Company, irrespective of the truthfulness or falsity of such statement.&#160; The Company agrees to not make any public statement (including any press release or official
              announcement) reflecting negatively on the Executive, including (without limitation) Executive's business, business reputation or personal reputation, and to direct its officers and directors not to disparage Executive, irrespective of the
              truthfulness or falsity of such statement. Nothing in this Section shall prohibit the Company or Executive from testifying truthfully in any forum or to any governmental agency, responding accurately and fully to any question, inquiry or
              request for information when required by legal process (e.g., a valid subpoena or other similar compulsion of law) or as part of a government investigation or in a dispute under this Agreement or otherwise.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Proprietary Information</u></font>.&#160; At all times the Executive shall hold in strictest confidence and will not disclose, use, lecture upon or publish any Proprietary Information (defined below) of the Company, except as such
            disclosure, use or publication may be required in connection with the Executive's work for the Company, or unless the Company expressly authorizes such disclosure in writing or it is required by law or in a judicial or administrative proceeding
            in which event the Executive shall, if legally permitted and at the cost of the Company, promptly notify the Company of the required disclosure and assist the Company if a determination is made to resist the disclosure.&#160; For purposes of this
            Section 12(d), "<font style="font-family: 'Times New Roman';"><u>Proprietary Information</u></font>" shall mean any and all confidential and/or proprietary knowledge, data or information of the Company or its respective affiliated entities,
            including (without limitation) any information relating to financial matters, investments, budgets, business plans, marketing plans, personnel matters, business contacts, products, processes, know-how, designs, methods, improvements,
            discoveries, inventions, ideas, data, programs, and other works of authorship; provided, that it shall not include any information that was known to the public prior to its disclosure to Executive or becomes generally known to the public or
            within the Company&#8217;s industry.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Invention Assignment</u></font>.&#160; All inventions, innovations, improvements, developments, methods, designs, analyses, reports, and all similar or related information which relates to either the Company's actual or anticipated
            business, research and development or existing or future products or services and which are conceived, developed or made by Executive while employed by the Company (the "Work Product") belong to the Company and not to the Executive.&#160; The
            Executive shall promptly disclose such Work Product to the Board and perform all actions reasonably requested by the Board (whether during or after the Term of this Agreement) to establish and confirm such ownership (including, without
            limitation, assignments, consents, powers of attorneys and other instruments).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Return of Property</u></font>.&#160; Except as expressly provided herein, promptly following Executive's termination of employment, Executive will deliver to the person designated by the Company all originals and copies of all
            documents and property of the Company in the Executive's possession or under the Executive's control.&#160; The Executive will not reproduce or appropriate for the <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Executive's own
              use, or for the use of others, any property, Proprietary Information or Work Product. Notwithstanding the foregoing, the Executive may retain copies of his individual personnel documents (such as tax and payroll records), rolodex and address
              book, iPads and mobile phone (subject to the Company having a reasonable opportunity to &#8220;scrub&#8221; the foregoing for Confidential Information of the Company in accordance with its general policies and practices), and the Company shall cooperate
              with the Executive in transferring to the Executive the mobile accounts (including phone numbers and billing) if in the Company&#8217;s name.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Injunctive Relief and Other Remedies with Respect to Covenants</u></font>. The Executive acknowledges and agrees that the covenants and obligations of the Executive set forth in this Section 12 relate to special, unique and
            extraordinary matters and that a violation of any of the terms of such covenants and obligations may cause the Company irreparable injury for which adequate remedies are not available at law. Therefore, the Executive agrees that the Company
            shall (i) be entitled to pursue an injunction, restraining order or such other equitable relief (without the requirement to post bond) restraining the Executive from committing any violation of the covenants and obligations contained in this
            Section 12 and (ii) have no further obligation to make any payments to the Executive hereunder following any finding by a court or an arbitrator that the Executive has engaged in a material violation of the covenants and obligations contained
            in this Section 12. These remedies are cumulative and are in addition to any other rights and remedies the Company may have at law or in equity. The Company may withhold amounts otherwise payable to the Executive and recoup amounts previously
            paid to the Executive under this Agreement upon any material violation of the covenants and obligations of this Section 12, to the extent such violation is not cured following written notice thereof by the Company to the Executive and a
            reasonable opportunity to cure, to the extent curable.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">13.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Obligations Upon Termination of Employment</u></font>.&#160; Upon and after the Executive's termination of employment with the Company and until such time as no obligations of the Executive to the Company hereunder exist, the Executive
            may provide a complete copy of this Agreement to any person, entity or association which the Executive proposes to be employed, affiliated, engaged, associated or to establish any business or remunerative relationship prior to the commencement
            of any such relationship.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">14.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Legal Fees and Expenses</u></font>. If the Executive asserts any claim in any contest (whether initiated by the Executive or by the Company) as to the validity, enforceability or interpretation of any provision of this Agreement,
            the Company shall pay the Executive's costs (or cause such costs to be paid) in so asserting, including, without limitation, reasonable attorneys' fees and expenses, if the Executive is the prevailing Party in such contest, as determined by the
            arbitrators selected pursuant to Section 18 hereof to resolve such contest or as determined pursuant to Section 12(g), as applicable. Any payment to Executive shall be made within thirty (30) days following the final decision rendered in such
            arbitration or other proceeding.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal;">15.</font><font style="font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <font style="font-family: 'Times New Roman';"><u><font style="font-family: 'Times New Roman';">Non-Exclusivity of Rights; Resignation from Boards</font></u><font style="font-family: 'Times New Roman';">.</font></font></font></div>
      <div style="font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal;">(a)</font><font style="font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <font style="font-family: 'Times New Roman';">Nothing in this Agreement shall prevent or limit the Executive's continuing or future participation in or rights under any benefit, bonus, incentive or other plan or program provided by the Company
            and for which the Executive may qualify; provided, however, that if the Executive becomes entitled to and receives the severance payments described in this Agreement, the Executive hereby waives the Executive's right to receive payments under
            any severance plan or similar program applicable to employees of the Company.</font></font></div>
      <div style="font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal;">(b)</font><font style="font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <font style="font-family: 'Times New Roman';">If the Executive's employment with the Company terminates for any reason, the Executive shall immediately resign from all boards of directors of the Company, any Subsidiaries and any other entities
            for which the Executive serves as a representative of the Company and any committees thereof.</font></font></div>
      <div style="font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal;">(c)</font><font style="font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Executive agrees that the Executive will be subject to any compensation clawback, recoupment, and anti-hedging and pledging policies that may be applicable to the Executive as an employee of the
            Company, as in effect from time to time and applicable generally to all senior executives of the Company and as approved by the Board or a duly authorized committee thereof.</font></font></div>
      <div style="font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal;">16.</font><font style="font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <font style="font-family: 'Times New Roman';"><u><font style="font-family: 'Times New Roman';">Entire Agreement; Amendments</font></u><font style="font-family: 'Times New Roman';">.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">This Agreement and the other
            agreements referred to herein contain the entire agreement between the Parties hereto and supersede any and all prior agreements and understandings concerning the Executive's employment by the Company, including but not limited to the Prior
            Agreements.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">This Agreement shall not be
            terminated, altered or otherwise amended, except pursuant to an instrument in writing signed by each of the Parties hereto (including any successors and legal representatives).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">17.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman';"><font style="font-weight: normal;"><u><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Notices</font></u></font><font style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">.&#160; </font><font style="color: rgb(0, 0, 0);">A</font>ll notices or other communications pursuant to this Agreement shall be in writing and shall be deemed to be sufficient if delivered personally, telecopied, sent by nationally recognized, overnight courier
            or mailed by registered or certified mail (return receipt requested), postage prepaid, to the Parties at the following addresses (or at such other address for a Party as shall be specified by like notice):</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">if to the Company, to:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Westinghouse Air Brake Technologies Corporation</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">30 Isabella Street</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Pittsburgh, Pennsylvania 15212</div>
      <div style="text-align: justify; margin-left: 144pt; font-family: 'Times New Roman'; font-size: 10pt;">Attention: General Counsel</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div>
        <div style="font-family: 'Times New Roman'; text-indent: 108pt;">(ii)&#160; <font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;&#160;&#160;&#160; </font>if to the Executive, to the address in the Company's personnel records.</div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">All such notices and other communications shall be deemed to have been delivered and received (A) in the case of personal delivery, on the date of such delivery, (B)
        in the case of delivery by telecopy, on the date of such delivery, (C) in the case of delivery by nationally recognized, overnight courier, on the Business Day following dispatch, and (D) in the case of mailing, on the third Business Day following
        such mailing.&#160; As used herein, "Business Day" shall mean any day that is not a Saturday, Sunday or a day on which banking institutions in the Commonwealth of Pennsylvania are not required to be open.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">18.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u><font style="font-family: 'Times New Roman'; font-weight: normal;">Arbitration</font></u><font style="font-family: 'Times New Roman'; font-weight: normal;">. Except to the extent provided in Section 12(g), any dispute or controversy arising under or in connection with this
              Agreement shall be resolved by binding arbitration. The arbitration shall be held in the City of Pittsburgh, Commonwealth of Pennsylvania, and except to the extent inconsistent with this Agreement, shall be conducted </font><font style="font-weight: normal;">by Judicial Arbitration and Mediation Services Inc. (&#8220;JAMS&#8221;) <font style="font-family: 'Times New Roman';">in accordance with the </font>then applicable JAMS rules (at the following web address:
              https://www.jamsadr.com/rules-employment-arbitration/) <font style="font-family: 'Times New Roman';">then in effect at the time of the arbitration, before a single retired judge, and otherwise in accordance with principles which would be
                applied by a court of law or equity. The arbitrator shall be acceptable to both the Company and the Executive. If the parties cannot agree on an acceptable arbitrator, the dispute shall be heard by a panel of three arbitrators, one </font>appoint</font>ed
            by each of the parties and the third appointed by the other two arbitrators.&#160; From and after a Change in Control, if the Executive asserts or defends against any claim in any contest (whether initiated by the Executive or by the Company) as to
            the validity, enforceability or interpretation of any provision of this Agreement, the Company shall pay the Executive's costs (or cause such costs to be paid) in so asserting, including, without limitation, reasonable attorneys' fees and
            expenses, if the Executive asserts or defends against any such claim in good faith. Any payment to the Executive shall be made within 30 days following the final decision rendered in such arbitration.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">19.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Miscellaneous Provisions</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(a)</font><font style="font-size: 10pt; font-weight: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u><font style="font-family: 'Times New Roman';">Descriptive Headings</font></u><font style="font-family: 'Times New Roman';">.&#160; </font>Descriptive headings are for convenience only and shall not control or affect the meaning or
            construction of any provisions of this Agreement. When the context admits or requires, words used in the masculine gender shall be construed to include the feminine, the plural shall include the singular, and the singular shall include the
            plural.</font></font></div>
      <div style="font-size: 10pt; font-weight: normal;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(b)</font><font style="font-size: 10pt; font-weight: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u><font style="font-family: 'Times New Roman';">Governing Law</font></u><font style="font-family: 'Times New Roman';">.&#160; </font>This Agreement shall be governed by and construed and enforced in accordance with the laws of the
            Commonwealth of Pennsylvania applicable to contracts made and performed wholly therein without regard to rules governing conflicts of law.</font></font></div>
      <div style="font-size: 10pt; font-weight: normal;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(c)</font><font style="font-size: 10pt; font-weight: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u><font style="font-family: 'Times New Roman';">Waiver of Breach</font></u><font style="font-family: 'Times New Roman';">.&#160; </font>No delay or omission by a Party in exercising any right, remedy or power under this Agreement or
            existing at law or in equity shall be construed as a waiver thereof, and any such right, remedy or power may be exercised by such Party from time to time and as often as may be deemed expedient or necessary by such Party in its sole discretion.</font></font></div>
      <div style="font-size: 10pt; font-weight: normal;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(d)</font><font style="font-size: 10pt;"><font style="font-weight: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman';"><u><font style="font-family: 'Times New Roman'; font-weight: normal;">Severability</font></u><font style="font-family: 'Times New Roman'; font-weight: normal;">.&#160; </font><font style="font-weight: normal;">In the event that any provision of this Agreement is determined to be partially or wholly invalid, illegal or unenforceable in any jurisdiction, then suc</font>h provision shall, as to such jurisdiction, be modified or restricted to
            the extent necessary to make such provision valid, binding and enforceable, or if such provision cannot be modified or restricted, then such provision shall, as to such jurisdiction, be deemed to be excised from this Agreement; provided,
            however, that the binding effect and enforceability of the remaining provisions of this Agreement, to the extent the economic benefits conferred upon the Parties by virtue of this Agreement remain substantially unimpaired, shall not be affected
            or impaired in any manner, and any such invalidity, illegality or unenforceability with respect to such provisions shall not invalidate or render unenforceable such provision in any other jurisdiction.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-weight: normal;"><u><font style="font-family: 'Times New Roman';">Benefits of Agreement; Assignment</font></u><font style="font-family: 'Times New Roman';">.&#160; </font>All of the terms and provisions of this Agreement shall be binding upon and inure to the benefit of
            and be enforceable by the respective heirs, executors, administrators, legal representatives, successors and assigns of the Parties hereto, except that the duties and responsibilities of the Executive under this Agreement are of a personal
            nature and shall not be assignable or delegable in whole or in part by the Executive.&#160; The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation, reorganization or otherwise) to all or substantially
            all of the business and/or assets of the Company, within fifteen (15) days of such succession, expressly to assume and agree to perform this Agreement in the same manner and to the same extent as the Company would be required to perform if no
            such succession had taken place<font style="font-family: 'Times New Roman';"> and the Executive acknowledges that in such event the obligations of the Executive hereunder, including but not limited to those under Sections 11 or 12, will
              continue to apply in favor of the successor</font>. As used in this Agreement, "Company" shall mean the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid which assumes this Agreement by operation of
            law, written assumption or otherwise.</font></font></div>
      <div style="font-size: 10pt; font-weight: normal;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(f)</font><font style="font-size: 10pt;"><font style="font-weight: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman';"><u><font style="font-family: 'Times New Roman'; font-weight: normal;">Remedies</font></u><font style="font-family: 'Times New Roman'; font-weight: normal;">.&#160; </font><font style="font-weight: normal;">All
              remedies hereunder are cumulative, are in addition to any other remedies provided for by law and may, to the extent permitted by law, be exercised concurrently or separately, and the exercise of any one remedy shall not be deemed to be an
              election of such remedy or to preclude the exercise of any other remedy. The Executive acknowledges that in the event of a breach of any of the Executive's covenants contained in <font style="font-family: 'Times New Roman';">Sections 11 or
                12</font>, t</font>he Company shall be entitled to pursue immediate relief enjoining such violations in any court or before any judicial body having jurisdiction over such a claim.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Withholding</u></font>.&#160; All payments under this Agreement shall be made subject to applicable tax withholding, and the Company shall withhold from any payments under this Agreement all federal, state and local taxes as the
            Company is required to withhold pursuant to any law or governmental rule or regulation.&#160; The Executive shall bear all expense of, and be solely responsible for, all federal, state and local taxes due with respect to any payment received under
            this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Compliance with Section 409A of the Code</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">This Agreement is intended to
            comply with section 409A of the Code and its corresponding regulations, to the extent applicable.&#160; Severance benefits under this Agreement are intended to be exempt from section 409A of the Code under the "short term deferral" exemption under
            Treasury Regulations section 1.409A-1(b)(4), to the maximum extent applicable, and then under the "separation pay" exemption under Treasury Regulations section 1.409A-1(b)(9)(iii), to the maximum extent applicable.&#160; If the parties in good faith
            believe that this Agreement is not in compliance with section 409A of the Code, the parties shall in good faith attempt to amend this Agreement to comply with section 409A of the Code while endeavoring to maintain the intended economic benefits
            hereunder.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Notwithstanding
            anything in this Agreement to the contrary, payments may only be made under this Agreement upon an event and in a manner permitted by section 409A of the Code, to the extent applicable.&#160; As used in this Agreement, the term "termination of
            employment" shall mean the Executive's "separation from service" with the Company within the meaning of section 409A of the Code and the regulations promulgated thereunder.&#160; In no event may the Executive, directly or indirectly, designate the
            calendar year of a payment.&#160;&#160; For purposes of section 409A of the Code, each payment hereunder shall be treated as a separate payment and the right to a series of payments shall be treated as the right to a series of separate payments.&#160; All
            reimbursements and in-kind benefits provided under this Agreement shall be made or provided in accordance with the requirements of section 409A of the Code. <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Notwithstanding any
              provision of this Agreement to the contrary, in no event shall the timing of the Executive's execution of the Release, directly or indirectly, result in the Executive designating the calendar year of payment, and if a payment that is subject
              to execution of the Release could be made in more than one taxable year, payment shall be made in the later taxable year.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Notwithstanding anything herein to
            the contrary, if, at the time of the Executive's termination of employment with the Company, the Company has securities which are publicly traded on an established securities market and the Executive is a "specified employee" (as such term is
            defined in section 409A of the Code) and it is necessary to postpone the commencement of any payments or benefits otherwise payable under this Agreement as a result of such termination of employment to prevent any accelerated or additional tax
            under section 409A of the Code, then the Company will postpone the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits ultimately paid or provided to the Executive) that are
            not otherwise paid within the "short-term deferral exception" under Treasury Regulations section 1.409A-1(b)(4), and the "separation pay exception" under Treasury&#160; Regulations section 1.409A-1(b)(9)(iii), until the first payroll date that
            occurs after the date that is six (6) months following the Executive's separation of service with the Company.&#160; If any payments are postponed due to such requirements, such postponed amounts will be paid in a lump sum to the Executive on the
            first payroll date that occurs after the date that is six (6) months following Executive's separation of service with the Company. If the Executive dies during the postponement period prior to the payment of postponed amount, the amounts
            withheld on account of section 409A of the Code shall be paid to the personal representative of the Executive's estate within sixty (60) days after the date of the Executive's death.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Full Settlement; No Mitigation</u></font>.&#160; In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of
            this Agreement and such amounts shall not be reduced as a result of a mitigation duty whether or not the Executive obtains other employment.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Government Agency Exception</u></font>. Nothing in this Agreement is intended to prohibit or restrict the Executive from: (i) making any disclosure of information required by process of law; (ii) providing information to, or
            testifying or otherwise assisting in any investigation or proceeding brought by, any federal or state regulatory or law enforcement agency or legislative body, or any self-regulatory organization; or (iii) filing, testifying, participating in,
            or otherwise assisting in a proceeding relating to an alleged violation of any federal, state, or municipal law relating to fraud or any rule or regulation of the Securities and Exchange Commission or any self-regulatory organization. In
            addition, this Agreement does not bar the Executive's right to file an administrative charge with the Equal Employment Opportunity Commission ("EEOC") and/or to participate in an investigation by the EEOC.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)</font><font style="font-size: 10pt;">&#160;&#160;<font style="font-weight: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u><font style="font-family: 'Times New Roman';">Survival</font></u><font style="font-family: 'Times New Roman';">.&#160; </font>The respective rights and obligations of the Parties hereunder shall survive the termination of this Agreement to the
              extent necessary to the intended preservation of such rights and obligations.</font></font></font></div>
      <div style="font-size: 10pt; font-weight: normal;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(l)</font><font style="font-size: 10pt; font-weight: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><font style="font-family: 'Times New Roman';"><u><font style="font-family: 'Times New Roman';">Counterparts</font></u><font style="font-family: 'Times New Roman';">.&#160; </font>This Agreement may be executed in any number of counterparts, and each such counterpart shall be
            deemed to be an original instrument, but all such counterparts together shall constitute but one agreement.&#160; This Agreement may be executed and delivered by facsimile.</font></font></div>
      <div style="font-size: 10pt; font-weight: normal;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">[Signature Page Follows]</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date and year first above written.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z1e7d836c20c44a8a81e6241ea30ebc6a">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">WESTINGHOUSE AIR BRAKE</div>
                <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;"> TECHNOLOGIES CORPORATION </div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: justify; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">Name:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">Title:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">EXECUTIVE</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;"><br>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">Name: Rafael Santana</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Exhibit A</u></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">General Release of Claims</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(see attached)</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>General Release of Claims</u></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">THIS RELEASE (the &#8220;<font style="font-family: 'Times New Roman';"><u>Release</u></font>&#8221;) is executed by Rafael Santana (&#8220;<font style="font-family: 'Times New Roman';"><u>Executive</u></font>&#8221;) for the benefit of Westinghouse Air Brake Technologies Corporation (the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;).</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, the entering into and non-revocation of this Release is a condition to Executive&#8217;s right to receive certain payments and benefits under the
        Severance and Employment Continuation Agreement, dated as of [DATE], by and between the Company and Executive (the &#8220;<font style="font-family: 'Times New Roman';"><u>Employment Agreement</u></font>&#8221;).&#160; Capitalized terms used and not defined herein
        shall have the meaning provided in the Employment Agreement.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, in consideration for Severance Benefits, to which Executive is not otherwise entitled, and the sufficiency of which Executive
        acknowledges, Executive represents and agrees, as follows:</div>
      <div style="text-align: left; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
        </font></div>
      <div style="text-align: left; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Release in Full of All Claims</u>.</font>&#160; Executive, for himself, his heirs, administrators, representatives, executors, successors and assigns (collectively &#8220;<font style="font-family: 'Times New Roman';"><u>Releasers</u></font>&#8221;),
            hereby irrevocably and unconditionally releases, acquits and forever discharges the Company or any of its parents, subsidiaries, divisions, affiliates and related entities and their current and former directors, officers, shareholders,
            trustees, employees, consultants, independent contractors, representatives, agents, servants, successors and assigns and all persons acting by, through or under or in concert with any of them (collectively &#8220;<font style="font-family: 'Times New Roman';"><u>Releasees</u></font>&#8221;), from all claims, rights and liabilities up to and including the date of this Release arising from or relating to Executive&#8217;s employment with the Company, its subsidiaries, and affiliates or the termination
            thereof and from any and all charges, complaints, claims, liabilities, obligations, promises, agreements, controversies, damages, actions, causes of action, suits, rights, demands, costs, losses, debts and expenses of any nature whatsoever,
            known or unknown, suspected or unsuspected (&#8220;<font style="font-family: 'Times New Roman';"><u>Claims</u></font>&#8221;).&#160; Executive acknowledges that the Claims released under this paragraph might arise under many different foreign, domestic,
            national, state, or local laws (including statutes, regulations, other administrative guidance, and common law doctrines), including, but not limited to, the following:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z13a2df02bf7e45b5b0b9bdbbc1422780">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Claims of breach of contract, whether express, implied or implied-in-fact, promissory estoppel, wrongful discharge, retaliatory discharge, interference with contractual relations or prospective
                economic advantage or violation of any duties of good faith and fair dealing;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3653d4a2739b4f0cb4a2cce1d6bc87c8">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Claims for salary, bonus compensation, incentive compensation, commissions, deferred compensation, premium payments, overtime compensation, stock rights, stock options, vacation, paid time off,
                sick leave, family leave, medical leave, fringe benefits or remuneration of any kind arising out of or relating to Executive&#8217;s employment by the Company up through the Date of Termination;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zae3cb93f8a9c45d5961d58fa2f356b7b">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Claims under or pursuant to the Americans with Disabilities Act, as amended, the Age Discrimination in Employment Act, as amended (the &#8220;<font style="font-family: 'Times New Roman';"><u>ADEA</u></font>&#8221;),
                Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights Act of 1991, the Equal Pay Act, United States Presidential Executive Orders 11246 and 11375, 42 U.S.C. &#167; 1981, as amended, the Family and Medical Leave Act, the
                Sarbanes-Oxley Act, the Worker Adjustment and Retraining Notification Act, the Genetic Information Nondiscrimination Act, and the Fair Labor Standards Act (including Claims for salary, bonus compensation, commissions, deferred compensation
                or remuneration of any kind), as well as any other federal law, statute, ordinance, rule, regulation or executive order relating to employment and/or discrimination in employment, and/or any Claims to attorneys&#8217; fees or costs under such
                statutes and laws<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">;</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze08e884f17b14bcea31e1b03a3293a93">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Claims under the Pennsylvania Human Relations Act, 43 <font style="font-family: 'Times New Roman'; font-variant: small-caps;">Pa. Cons. Stat.</font> &#167;&#167; 951 &#8211; 963, the Pennsylvania Minimum Wage
                Act, 43 <font style="font-family: 'Times New Roman'; font-variant: small-caps;">Pa. Cons. Stat.</font> &#167;&#167;333.101 -333.115, the Pennsylvania Wage Payment and Collection Law, 43 <font style="font-family: 'Times New Roman'; font-variant: small-caps;">Pa. Cons. Stat.</font> &#167; 260.1 et seq., the Pennsylvania Whistleblower Law, and any other Claims under any Pennsylvania statutes, as well as any other state or local law, statute, ordinance, rule, regulation or executive
                order relating to employment and/or discrimination in employment, and/or any Claims to attorneys&#8217; fees or costs under such statutes and laws;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcb0a3fa3da344bdfb15f333e78191fe5">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Claims for intentional torts, negligence, negligent or intentional infliction of emotional distress, personal, emotional or physical injury, fraud, defamation, libel, slander, misrepresentation,
                violation of public policy, invasion of privacy, or any other statutory or common law tort theory of recovery; and</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z922135500025450e982fc691007bee42">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Claims arising under the Employee Retirement Income Security Act of 1974, as amended (&#8220;<font style="font-family: 'Times New Roman';"><u>ERISA</u></font>&#8221;), or pertaining to ERISA-regulated
                benefits, including any claims for severance pay, welfare benefits, unvested retirement benefits or other remuneration or benefits of any kind or character.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 45.35pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Unknown Claims</u></font>.&#160; Executive acknowledges that Executive is releasing claims that Executive may not know about, and that Executive does so with knowing and voluntary intent.&#160; Executive expressly waives
            all rights that Executive may have under any law that is intended to protect Executive from waiving unknown Claims.&#160; Executive further acknowledges that Executive understands the significance of doing so.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>No Claims Filed</u></font>.&#160; Executive affirms that, as of the date of execution of this Release, Executive has filed no lawsuit, charge, claim or complaint with any governmental agency or in any court against
            the Company or any of the other Releasees relating to any Claims.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Exclusions for Certain Claims</u></font>.&#160; Notwithstanding the foregoing, Executive and the Company agree that this Release specifically excludes (i) Executive&#8217;s rights and the Company&#8217;s obligations under the
            Employment Agreement, (ii) applicable statutory rights to indemnification for actions taken within the scope of his employment and his service as an officer of the Company or any of its subsidiaries, which shall include the availability of all
            insurance coverage that may apply to such claims, and (iii) claims that may not, as a matter of law, be released.&#160; Further, Executive and the Company agree that nothing herein shall be construed to prevent Executive from enforcing rights, if
            any, under ERISA to recover any vested benefits or instituting any action to enforce the terms of this Release.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Government Investigations</u></font>.&#160; The parties agree that nothing in this Release shall be construed to prohibit Executive from filing a charge with the Equal Employment Opportunity Commission (hereinafter &#8220;<font style="font-family: 'Times New Roman';"><u>EEOC</u></font>&#8221;) to enforce the ADEA and other laws, the Securities Exchange Commission or other similar governmental agency, or from participating in investigations with such entities.&#160; However,
            Executive acknowledges that by executing this Release, Executive waives his right to seek or accept individual remedies or monetary damages in any such action or lawsuit arising from such charges or investigations, or in connection with any
            complaint or charge that Executive may file with an administrative agency, including, but not limited to, reinstatement, back pay, front pay, damages, attorneys&#8217; fees or experts&#8217; fees, except with respect to any monetary recovery under the
            Dodd-Frank Wall Street Reform and Consumer Protection Act and the Sarbanes-Oxley Act of 2002 or Section 21F of the Securities Exchange Act of 1934.&#160; Executive further agrees that if any person, organization or other entity should bring a claim
            against the Releasees involving any matter covered by this Release, Executive will not accept any personal relief in any such action, including damages, attorneys&#8217; fees, costs and all other legal or equitable relief.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 31.5pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160; Executive further understands that nothing contained herein is intended to interfere with or discourage Executive&#8217;s good faith disclosure to any
        governmental entity regarding possible legal violations or otherwise testifying or participating in any investigation or proceeding by any governmental authorities regarding possible legal violations, and nothing contained herein waives or releases
        Executive&#8217;s right to receive money for disclosing such information to a government agency.&#160; Executive further understands that Executive will not be subject to retaliation by the Company for a disclosure made pursuant to this paragraph.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>ADEA/OWBPA Waiver and Acknowledgement</u></font>.&#160; Executive and the Company desire and intend that this Release comply with the terms of the Older Workers&#8217; Benefit Protection Act.&#160; Accordingly, Executive
            acknowledges that Executive has been advised of the following rights:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcf4b7cacd4d8453585a6bc9bd41d172f">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Executive understands that state and federal laws, including the AGE DISCRIMINATION IN EMPLOYMENT ACT, prohibit employment discrimination based upon age, sex, race, color, national origin,
                ethnicity, religion, or disability.&#160; Executive further understands and agrees that, by signing this Release, Executive agrees to waive any and all such claims and releases the Company from any and all such claims.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9ab9d649b9ba4d9091465ebbc2cd3cf9">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Executive acknowledges that Executive has been advised in writing to consult with an attorney and has been provided with a reasonable opportunity to consult with an attorney concerning the terms
                and conditions of this Release prior to signing this Release, which contains a general release and waiver of claims.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7aff17a66b9e4fa4891a2feb08d3ba8c">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Executive acknowledges that the Severance Benefits being provided to Executive pursuant to the terms of the Employment Agreement constitute benefits to which Executive otherwise would not be
                entitled, and that Executive has been provided with adequate and valuable consideration for signing this Release.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4b383c9656ea4ff8ad8e88a04e881c70">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Executive acknowledges that Executive has at least TWENTY-ONE (21) DAYS after receiving this Release to consider whether to sign this Release.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z48d81dd9685d434d931e674b780aaaed">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Executive acknowledges that, in the event that Executive signs this Release, Executive has another SEVEN (7) DAYS to revoke it.&#160; To revoke this Release, Executive must deliver a written notice of
                revocation to Ms. Nicole B. Theophilus, Executive Vice President, Chief Human Resources Officer, Wabtec Corp., 30 Isabella Street, Pittsburgh, PA, 15212, prior to 5 PM Eastern Time on the seventh day after signing this Release.&#160; THIS
                RELEASE<font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;</font>SHALL NOT BECOME EFFECTIVE UNTIL AFTER THE EXPIRATION OF THIS SEVEN (7) DAY PERIOD.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Governing Law</u></font>.&#160; This Release will be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania, without giving effect to any choice of law or conflicting provision or
            rule (whether of the Commonwealth of Pennsylvania or any other jurisdiction) that would cause the laws of any jurisdiction other than the Commonwealth of Pennsylvania to be applied.&#160; In furtherance of the foregoing, the internal law of the
            Commonwealth of Pennsylvania will control the interpretation and construction of this Release, even if under such jurisdiction&#8217;s choice of law or conflict of law analysis, the substantive law of some other jurisdiction would ordinarily apply.&#160;
            Further, to the extent that Executive or the Company is required to initiate legal action to enforce any right or obligation under this Release, Executive and the Company agree that any such litigation shall be filed and determined by the
            United States District Court for the Western District of Pennsylvania or the Court of Common Pleas for Allegheny County;<font style="font-family: 'Times New Roman'; font-style: italic;">&#160;</font>and both Executive and the Company consent to the
            exclusive personal jurisdiction of such courts.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">8.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Severability</u></font>.&#160; The provisions of this Release are severable, and if any part or portion of it is found to be unenforceable, the other paragraphs shall remain fully valid and enforceable.&#160; The waiver
            of a breach of any of the provisions of this Release shall not operate or be construed as a waiver of any other provision of this Release or a waiver of any subsequent breach of the same provision.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">9.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Voluntary Execution</u></font>.&#160; Executive acknowledges that Executive is executing this Release voluntarily and of Executive&#8217;s own free will and that Executive fully understands and intends to be bound by the
            terms of this Release.&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Further,</font> Executive <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">acknowledges that </font>Executive <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">received a copy of this Release on [DATE], that </font>Executive <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">has carefully read and fully understands all of
              the provisions and effects of this Release; that </font>Executive <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">has been advised to consult with an attorney prior to executing this Release; that </font>Executive <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">participated in the creation of and is voluntarily entering into this Release; and that neither the Company nor its agents or attorneys have made any representations or promises as
              to the terms or effects of this Release other than those contained in this Release.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>No Assignment of Claims</u></font>.&#160; Executive represents and warrants that Executive has not previously assigned or purported to assign or transfer to any person or entity any of the claims or causes of action
            herein released.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">THIS RELEASE SHALL BECOME EFFECTIVE AND ENFORCEABLE ON THE EIGHTH DAY FOLLOWING ITS EXECUTION BY EXECUTIVE, PROVIDED HE DOES NOT EXERCISE HIS RIGHT OF
        REVOCATION AS DESCRIBED ABOVE.&#160; IF EXECUTIVE FAILS TO SIGN AND DELIVER THIS RELEASE OR REVOKES HIS SIGNATURE, THIS RELEASE WILL BE WITHOUT FORCE OR EFFECT, AND EXECUTIVE SHALL NOT BE ENTITLED TO THE SEVERANCE BENEFITS.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[Signature on Following Page]</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">IN WITNESS WHEREOF</font><font style="font-size: 10pt;">, Executive has executed and
          delivered this Release on the date set forth below.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z5e7bfc9cea1c433a829367c45862dd93">

          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman';">Dated:</div>
            </td>
            <td style="width: 40%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;"><br>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; padding-bottom: 2px;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;"><br>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">Name:&#160; <br>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">Rafael Santana</td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Acknowledged and Agreed:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z524568d53420445ea60e0d263cf08033">

          <tr>
            <td colspan="3" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">WESTINGHOUSE AIR BRAKE</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">TECHNOLOGIES CORPORATION</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Exhibit B</u></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Competition and Non-Solicitation Covenants</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Non-Competition</u></font>.&#160; Because of the Company's legitimate business interest and the valuable consideration offered to the Executive to which Executive would not otherwise be entitled, including as described in Section 6 and
            10, and except where prohibited by state or local law, the Executive covenants and agrees that during the Executive's period of employment with the Company and for a period of one (1) year after Executive ceases to be employed by the Company,
            the Executive will not directly or indirectly, on the Executive's own behalf or on behalf of or in conjunction with any person, business, firm, company, or other entity, set up, join, become employed by, be engaged in, or provide any advice or
            services to, any enterprise which develops, produces, markets, sells or services any product or service which (a) is the same as or similar to products or services manufactured and sold by the business or function the Executive worked for in
            the last two years of employment with the Company and (b) accounted for at least five percent (5%) of the Company&#8217;s income from operations for its most recently completed fiscal year. This covenant is limited to any state in the United States
            of America and country in which the Company is or has been doing business during the twelve (12) months prior to the Executive's date of termination. This covenant does not prohibit the Executive from purchasing or owning less than five percent
            (5%) of the publicly traded securities of any corporation, provided that the Executive's ownership represents a passive investment and that the Executive is not a controlling person of, or a member of a group that controls, the corporation. The
            Executive acknowledges that as an executive, the Executive has access to Company-wide confidential strategic information and customer information for the Executive's business or function, that disclosure of that information to a competitor or
            use of that information by a competitor would cause the Company irreparable harm, that this covenant is reasonably necessary to protect that information, and that the Executive has received sufficient consideration for the covenants contained
            herein. The Executive agrees that a court may modify any provision herein that it deems unreasonable or unenforceable, and the remainder shall remain in full force and effect. The Executive acknowledges that, if required by applicable law, the
            Company advised the Executive to consult with an attorney before agreeing to this covenant and provided the Executive with at least 14 days to review and consider this covenant before agreeing to it.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Non-Solicitation</u></font>.&#160; Because of the Company's legitimate business interest and the valuable consideration offered to the Executive to which the Executive would not otherwise be entitled, including as described in Section
            4 and 8, and except where prohibited by state or local law, the Executive covenants and agrees that for a period of one (1) year after the Executive ceases to be employed by the Company, the Executive will not, for his or herself, as an agent
            or employee, or on behalf of any person, association, partnership, corporation or other entity, directly or indirectly, solicit the business, or aid to assist anyone else in the solicitation of business from, any customer or prospective
            customer of the Company or supplier of parts used in the manufacturing of products by the Company with whom the Executive had direct or indirect contact or about whom the Executive may have acquired any knowledge while employed by or through
            the Executive's employment with the Company. The Executive also agrees that, during the Executive's employment with the Company and for one (1) year after the Executive ceases to be employed by the Company, the Executive will not, directly or
            indirectly: solicit or induce, or attempt to solicit or induce, any employee of the Company to leave the Company for any reason whatsoever, or hire or participate in the hiring or interviewing of any employee of the Company; or provide names or
            other information about the Company's employees for the purpose of assisting others to hire or interview such employees. For purposes of this paragraph, a Company employee means any person who is a current Company employee or was employed by
            the Company within the six (6) months preceding any alleged solicitation of any action by the Executive that violates this covenant. Notwithstanding the foregoing, the Executive is permitted to have general advertisements, marketing or
            recruiting efforts in the market as long as they are not directed at Company employees or customers.&#160; The Executive acknowledges that this covenant is reasonable, and that the Executive has received sufficient consideration for the covenants
            contained herein. The Executive agrees that a court may modify any provision herein that it deems unreasonable or unenforceable, and the remainder shall remain in full force and effect. The Executive acknowledges that, if required by applicable
            law, the Company advised the Executive to consult with an attorney before agreeing to this covenant and provided the Executive with at least 14 days to review and consider this covenant before agreeing to it.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>brhc10045145_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solution Inc.
         Document created using Broadridge PROfile 22.10.2.5096
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.2</font><br>
  </div>
  <div style="text-align: right;"><font style="font-weight: bold;"> <br>
    </font></div>
  <div style="text-align: center; font-weight: bold;">SEVERANCE AND EMPLOYMENT CONTINUATION AGREEMENT</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt;">THIS SEVERANCE AND EMPLOYMENT CONTINUATION AGREEMENT (this "Agreement") is entered into as of December 5, 2022 (the "Effective Date") by and between Westinghouse Air Brake Technologies Corporation, a
    Delaware corporation (the "Company") and [Executive] (the "Executive") (each referred to herein as a "Party", and, collectively, the "Parties").</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt;">WHEREAS, this Agreement replaces and supersedes all previous agreements between the Executive and the Company concerning the subject matter herein.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt;">NOW, THEREFORE, in consideration of the premises and of the mutual promises and covenants contained herein, the Company and the Executive, intending to be legally bound, hereby agree as follows:</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Definitions</u>.&#160; For purposes of this Agreement, the terms listed in this Section 1 have the meanings set forth herein and are supplemented by the information set forth in the Exhibit A
    to this Agreement.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Accrued Obligations</u>. "Accrued Obligations" shall mean (i) any Base Salary earned through the Executive's termination of employment that remains unpaid; (ii) any annual incentive
    bonus payable with respect to any fiscal year which ended prior to the effective date of the Executive's termination of employment, which remains unpaid; (iii) any accrued but unused personal time off days; (iv) any unpaid reimbursement due to the
    Executive on or prior to the date of such termination of employment under the Company's expense reimbursement policy; and (v) any vested and non-forfeitable employee benefits to which Executive is entitled upon termination of the Executive's employment
    with the Company in accordance with the terms and conditions of any applicable plan or award agreement.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Act.</u>&#160; "Act" shall mean the Securities Exchange Act of 1934, as amended.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Base Salary</u>.&#160; "Base Salary" shall mean the annual base salary paid by the Company as of the date of termination of employment (without regard to any reduction that gives rise to
    Good Reason).</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Board</u>.&#160; "Board" shall mean the Board of Directors of the Company.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Cause</u>.&#160; "Cause" shall mean any of the following grounds for the Executive's termination of employment: (i) conviction of, or plea of nolo contendere to, a felony or a crime
    involving moral turpitude; (ii) an act or acts of dishonesty or gross misconduct which results or is intended to result in material damage to the Company's business or reputation; (iii) any material violation of Company insider trading policies, any
    Company employment policies, or the Company's code of conduct; or (iv) willful and continued failure to substantially perform the required duties with the Company (other than any such failure resulting from incapacity due to physical or mental illness
    or Disability or any actual or anticipated failure after a termination for Good Reason) after a written demand for substantial performance is delivered to Executive by the Company, which demand specifically identifies the manner in which the Company
    believes that Executive has not substantially performed the required duties.</div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <!--PROfilePageNumberReset%Num%2%%%-->
  <div style="text-align: justify; text-indent: 72pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Change in Control</u>.&#160; a "Change in Control" shall mean the date upon which any of the following events occur:</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company acquires actual knowledge that any Person (as that term is used in Sections 13(d) and 14(d) of the Act), other than the Company, a subsidiary, or any employee benefit plan(s) sponsored by the
    Company or a subsidiary, has acquired the Beneficial Ownership (as determined under Rule 13d-3 under the Act), directly or indirectly, of securities of the Company entitling such Person to 30% or more of the Voting Power of the Company;</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;At any time less than 51% of the members of the Board (excluding vacant seats) shall be Continuing Directors; or</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The consummation of a merger, consolidation, share exchange, division or sale or other disposition of assets of the Company as a result of which the stockholders of the Company immediately prior to such
    transaction shall not hold, directly or indirectly, immediately following such transaction a majority of the Voting Power, and in substantially the same proportions as they held prior to such transaction, of (A) in the case of a merger or
    consolidation, the surviving or resulting corporation, (B) in the case of a share exchange, the acquiring corporation or (C) in the case of a division or a sale or other disposition of assets, each surviving, resulting or acquiring corporation which,
    immediately following the transaction, holds more than 30% of the consolidated assets of the Company immediately prior to the transaction.</div>
  <div>&#160;</div>
  <div>Notwithstanding the foregoing, if required in order to comply with section 409A of the Code, then for purposes of payment of any amount upon the Change in Control, no Change in Control shall be deemed to have occurred upon an event described in
    items (i) - (iii) above unless the event would also constitute a change in ownership or effective control of, or a change in the ownership of a substantial portion of the assets of, the Company under section 409A of the Code.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Change in Control Period</u>. "Change in Control Period" shall mean the period commencing on the effective date of a Change in Control and ending on the second anniversary of such
    Change in Control.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>CIC Termination</u>. "CIC Termination" shall mean termination of the Executive's employment by the Company without Cause or by the Executive for Good Reason during the Change in Control
    Period, provided that, in either case, a Change in Control actually occurs.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Code</u>. "Code" shall mean the Internal Revenue Code of 1986, as amended.</div>
  <div>&#160;</div>
  <div style="text-indent: 72pt;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Committee.</u> "Committee" shall mean the Compensation Committee of the Board or its delegate designated consistent with applicable law.</div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Continuing Directors</u>. "Continuing Directors" shall mean a director of the Company who either (a) was a director of the Company on the Effective Date or (b) is an individual whose
    election, or nomination for election, as a director of the Company was approved by a vote of at least two-thirds of the directors then still in office who were Continuing Directors (other than an individual whose initial assumption of office is in
    connection with an actual or threatened election contest relating to the election of directors of the Company which would be subject to Rule 14a-11 under the Act, or any successor rule).</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Disability</u>. "Disability" shall have the meaning as set forth in section 409A(a)(2)(C) of the Code.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Good Reason</u>. "Good Reason" shall mean the occurrence of one or more of the following, without the Executive's consent:</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;An assignment of duties inconsistent in any way materially adverse to the Executive's position, authority, responsibilities, title or status;</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any other material adverse change in position, responsibilities, authority, title or status, including the Executive ceasing to hold the position and title held immediately before a Change in Control, or a
    substantially similar position, or removal from such position or failure to re-elect the Executive to such position (other than due to Cause, Disability, retirement, death or other termination of employment in accordance with this Agreement);</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material reduction in the Executive's salary or incentive compensation opportunity;</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Failure of the Company to comply with any material provision of this Agreement, including a purported termination of employment by the Company other than in accordance with this Agreement;</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Change in the geographic location of the Executive's offices of more than thirty-five (35) miles from the location of such offices immediately prior to the relocation; or</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Failure of the Company to obtain assumption of this Agreement by a successor entity.</div>
  <div>&#160;</div>
  <div style="text-align: justify;">The Executive must provide written notice of termination of employment for Good Reason to the Company within sixty (60) days after the event constituting Good Reason first occurs, which notice shall state such Good
    Reason in reasonable detail.&#160; The Company shall have a period of thirty (30) days in which it may correct the act or failure to act that constitutes the grounds for Good Reason as set forth in the Executive's notice of termination of employment.&#160; If
    the Company does not correct the act or failure to act, the Executive must terminate the Executive's employment for Good Reason within sixty (60) days after the end of the cure period, in order for the termination of employment to be considered a Good
    Reason termination of employment.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Monthly Benefits Costs</u>. "Monthly Benefits Costs" shall mean an amount equal to the Company&#8217;s portion of the monthly premium cost of the medical, dental, and vision insurance
    coverage the Company provides to the Executive as of the date of Executive's termination of employment.</div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Pro-Rated Annual Bonus</u>. "Pro-Rated Annual Bonus" shall mean the annual bonus amount the Executive would be entitled to receive for the fiscal year in which the Executive&#8217;s
    employment terminates, based on the actual achievement of the applicable Company performance goals for such year (and with any subjective goals treated as achieved at not less than target, and without the application of any negative discretion by the
    Board) as determined as of the end of the fiscal year, prorated based on the number of days Executive was employed during the fiscal year of Executive&#8217;s termination, paid at the same time as the Company pays annual bonuses for such fiscal year to other
    executives.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Release</u>. "Release" shall mean a written release of any and all claims against the Company and its affiliates, with respect to all matters arising out of the Executive's employment
    with the Company, in the form provided by the Company.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Target Annual Bonus</u>.&#160; "Target Annual Bonus" shall mean the Executive's target annual incentive bonus amount (measured at the target level, identified "goal" target or other similar
    target, without taking into account any incentive override for above goal performance, or any project-specific or other non-standard incentives) as in effect under the Company's applicable annual bonus plan for the year of the Executive's termination
    of employment.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Voting Power</u>. "Voting Power" shall mean such number of the Voting Shares as shall enable the holders thereof to cast such percentage of all the votes which could be cast in an
    annual election of directors (without consideration of the rights of any class of stock other than the common stock of the Company to elect directors by a separate class vote); and "<u>Voting Shares</u>" shall mean all securities of the Company
    entitling the holders thereof to vote in an annual election of directors (without consideration of the rights of any class of stock other than the common stock of the Company to elect directors by a separate class vote).</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Term</u>.&#160; This Agreement shall commence on the Effective Date and shall continue until terminated pursuant to the terms of this Agreement (the "Term").</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Termination of Employment Without Cause or Resignation for Good Reason.</u>&#160; The Company may terminate the Executive's employment with the Company at any time without Cause upon not less
    than thirty (30) days' prior written notice to the Executive, and the Executive may resign for Good Reason according to the process set forth in Section 1(m).</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Payment and Benefits Upon a Termination of Employment Without Cause or Resignation for Good Reason Other than During a Change in Control Period</u>.</div>
  <div>&#160;</div>
  <div style="text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the Executive's employment is terminated by the Company without Cause or by the Executive for Good Reason, other than during a Change in Control Period, if the Executive executes and does not revoke the
    Release in accordance with Section 4(b), and so long as the Executive continues to comply with the provisions of Section 10 below, in addition to the Accrued Obligations, the Executive shall be entitled to receive the following:</div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day following the date of termination, a lump sum payment equal to the sum of (A) the Executive's Base Salary plus
    1/52 of the Executive's Base Salary for each full year of the Executive's service with the Company and (B) Executive's Target Annual Bonus; provided, however, that the amount described in clause (A) shall not exceed in the aggregate an amount equal to
    one and a half (1.5) times Base Salary;</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day following the date of termination, a lump sum payment equal to the Monthly Benefits Cost multiplied by the
    number of full months of Base Salary that is represented by the Base Salary severance payment determined in accordance with subsection (a)(i)(A) above;</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payment of a Prorated Annual Bonus at the same time and on the same terms as annual bonuses for the year of the Executive's termination are paid to other executives of the Company, but in any event no later
    than March 15 of the calendar year following the calendar year in which the Executive's termination of employment occurs;</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day following the date of termination, payment of a lump sum amount of $50,000 to defray transition costs; and</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Effective as of the date of termination, each outstanding equity award that was granted to the Executive on or after January 1, 2022 and is held by the Executive immediately prior to the date of termination
    (each, a "Post-2021 Equity Grant") shall be treated in accordance with the following terms, except to the extent that the applicable award agreement provides for more favorable treatment to the Executive: (A) a pro-rata portion of each Post-2021 Equity
    Grant which vests based upon the Executive's continued service over time shall become vested and/or exercisable, as the case may be, based on the portion of the vesting period that has elapsed as of the date of termination, and shall be paid according
    to the terms of the grant agreement; (B) a pro-rata portion of each Post-2021 Equity Grant which vests based upon attainment of performance criteria shall remain outstanding (based on the portion of the vesting period that has elapsed as of the date of
    termination) and shall vest based on performance during the applicable performance period pursuant to the terms and conditions of the agreement evidencing such performance-based award; (C) after giving effect to clauses (A) and (B), the vested portion
    of each Post-2021 Equity Grant that is a stock option or stock appreciation right shall be exercisable until the earlier of (x) the expiration date of such stock option or stock appreciation right under the grant agreement or (y) the third anniversary
    of the date of termination; and (D) the unvested portion of any Post-2021 Equity Grant after giving effect to clauses (A) and (B) shall be forfeited; </div>
  <div>&#160;</div>
  <div>Provided, however, that the payment dates set forth in this Section 4(a) shall be subject to the requirements set forth in Section 17(h), if applicable, in all respects. Outstanding equity awards that were granted to the Executive prior to January
    1, 2022 shall be subject to the terms of the applicable award agreements.</div>
  <div>&#160;</div>
  <div style="text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Release</u>. Notwithstanding anything herein to the contrary, the Company shall not be obligated to make any payment under Section 4(a) of this Agreement unless (i) prior to the 60th day following the
    Executive's date of termination (or such other date as may be required by law), Executive executes a Release, and (ii) any applicable revocation period has expired during such 60-day period without Executive revoking such Release.&#160; If the Executive
    does not sign, or the Executive revokes, the Release, no other payments or benefits shall be due under this Agreement to the Executive other than the Accrued Obligations.</div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-indent: 36pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Death and Disability</u>.&#160; If the Executive's employment is terminated by reason of the Executive's death or Disability, then the Executive, or the Executive's estate, as applicable, shall be entitled to
    receive payment of the Accrued Obligations and a Pro-Rated Annual Bonus, payable at the same time and on the same terms as annual bonuses for the year of the Executive's termination are paid to other executives of the Company, but in any event no later
    than March 15 of the calendar year following the calendar year in which the Executive's termination of employment occurs.&#160; Outstanding equity awards shall be subject to the terms of the applicable award agreements; provided, however, that vesting
    treatment shall include full vesting upon termination of employment due to death or Disability, subject to adjustment for performance during the applicable performance period for any such awards that vest based on attainment of performance criteria.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt;">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Cause</u>.&#160; The Company may terminate the Executive's employment at any time for Cause, in which event the Executive shall be entitled to receive payment of the Accrued Obligations.&#160;
    Outstanding equity awards shall be subject to the terms of the applicable award agreements.</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Voluntary Termination other than for Good Reason</u>. The Executive may, upon not less than thirty (30) days' written notice to the Company, voluntarily terminate his or her employment for any reason other
    than Good Reason, in which event the Executive shall be entitled to receive payment of the Accrued Obligations.&#160; Outstanding equity awards shall be subject to the terms of the applicable award agreements.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt;">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Payment and Benefits Upon a CIC Termination</u>.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>CIC Termination</u>.&#160; Notwithstanding anything to the contrary herein, if a CIC Termination occurs, if the Executive executes and does not revoke the Release in accordance with Section
    8(b), and so long as the Executive continues to comply with the provisions of Section 10 below, in addition to the Accrued Obligations, the Executive shall be entitled to receive the following:</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day following the date of the CIC Termination, a single lump sum payment of an amount equal to two (2) times
    Executive's Base Salary and two (2) times Executive's Target Annual Bonus;</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day following the date of the CIC Termination, a lump sum payment equal to the Monthly Benefits Cost multiplied by
    twenty-four (24);</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payment of a Prorated Annual Bonus at the same time and on the same terms as annual bonuses for the year of the Executive's termination are paid to other executives of the Company, but in any event no later
    than March 15 of the calendar year following the calendar year in which the Executive's termination of employment occurs;</div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-indent: 108pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day following the date of the CIC Termination, payment of a lump sum amount of $50,000 to defray transition costs;
    and</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Effective as of the date of the CIC Termination, except to the extent that the applicable award agreement provides for more favorable treatment to the Executive, (A) all Post-2021 Equity Grants held by the
    Executive immediately prior to the CIC Termination which vest based upon the Executive's continued service over time shall accelerate, become fully vested and/or exercisable, as the case may be, as of the date of the CIC Termination, and shall be paid
    according to the terms of the grant agreement, (B) all Post-2021 Equity Grants held by the Executive immediately prior to the CIC Termination which vest based upon attainment of performance criteria shall become immediately vested assuming maximum
    performance results and shall be paid according to the terms of the applicable award agreement, and (C) each Post-2021 Equity Grant that is a stock option or stock appreciation right held by the Executive shall be exercisable until the earlier of (x)
    the expiration date of such stock option or stock appreciation right under the grant agreement or (y) the third anniversary of the date of termination;</div>
  <div>&#160;</div>
  <div>Provided, however, that the payment dates set forth in Section 8(a) shall be subject to the requirements set forth in Section 17(h) in all respects. Outstanding equity awards that were granted to the Executive prior to January 1, 2022 shall be
    subject to the terms of the applicable award agreements.</div>
  <div>&#160;</div>
  <div style="text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Release</u>. Notwithstanding anything herein to the contrary, the Company shall not be obligated to make any payment under Section 8(a) of this Agreement unless (i) prior to the 60th day following the
    Executive's date of termination (or such other date as may be required by law), the Executive executes a Release, and (ii) any applicable revocation period has expired during such 60-day period without the Executive revoking such Release. If the
    Executive does not sign, or the Executive revokes, the Release, no other payments or benefits shall be due under this Agreement to the Executive other than the Accrued Obligations.</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Section 280G</u>.&#160; In the event of a change in ownership or control under section 280G of the Code, if it shall be determined that any payment or distribution in the nature of compensation (within the
    meaning of section 280G(b)(2) of the Code) to or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise (a "Payment"), would constitute an "excess parachute
    payment" within the meaning of section 280G of the Code, the aggregate present value of the Payments under the Agreement shall be reduced (but not below zero) to the Reduced Amount (defined below) if and only if the Accounting Firm (described below)
    determines that the reduction will provide the Executive with a greater net after-tax benefit than would no reduction.&#160; No reduction shall be made unless the reduction would provide Executive with a greater net after-tax benefit.&#160; The determinations
    under this Section shall be made as follows:</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The "Reduced Amount" shall be an amount expressed in present value which maximizes the aggregate present value of Payments under this Agreement without causing any Payment under this
    Agreement to be subject to the Excise Tax (defined below), determined in accordance with section 280G(d)(4) of the Code.&#160; The term "Excise Tax" means the excise tax imposed under section 4999 of the Code, together with any interest or penalties imposed
    with respect to such excise tax.</div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payments under this Agreement shall be reduced on a nondiscretionary basis in such a way as to minimize the reduction in the economic value deliverable to the Executive. Where more than
    one payment has the same value for this purpose and they are payable at different times, they will be reduced on a pro rata basis.&#160; Only amounts payable under this Agreement shall be reduced pursuant to this Section.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All determinations to be made under this Section shall be made by an independent nationally recognized accounting firm or compensation consultant selected by the Company and agreed to by
    the Executive immediately prior to the change-in-ownership or -control transaction (the "Accounting Firm").&#160; The Accounting Firm shall provide its determinations and any supporting calculations both to the Company and the Executive within 10 days of
    the transaction.&#160; Any such determination by the Accounting Firm shall be binding upon the Company and the Executive.&#160; The Company and the Executive shall cooperate in case of a potential change in ownership or control of the Company to in good faith
    consider alternatives to mitigate any Section 280G exposure, including the valuation of any noncompetition covenants and/or acceleration of incentive compensation, although the Company cannot guaranty any such alternative arrangements&#160; will be
    available or approved by the Company and neither the Executive nor the Company shall be obligated to enter into any such arrangements. All of the fees and expenses of the Accounting Firm in performing the determinations referred to in this Section
    shall be borne solely by the Company.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt;">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Restrictive Covenants</u>.</div>
  <div>&#160;</div>
  <div style="text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Confidential Information</u>.</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Executive shall hold in a fiduciary capacity for the benefit of the Company all secret or confidential information, knowledge or data relating to the Company or any of its affiliated companies, and their
    respective businesses, (A) obtained by the Executive during the Executive's employment by the Company or any of its affiliated companies and (B) not otherwise public knowledge (other than by reason of an unauthorized act by the Executive). After
    termination of the Executive's employment with the Company, the Executive shall not, without the prior written consent of the Company, unless compelled pursuant to an order of a court or other body having jurisdiction over such matter, communicate or
    divulge any such information, knowledge or data to anyone other than the Company and those designated by it.</div>
  <div>&#160;</div>
  <div style="text-indent: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No Company policy or individual agreement between the Company and the Executive (including this Agreement) shall prevent the Executive from providing, without prior notice to the Company, information to
    government authorities regarding possible legal violations, participating in investigations, testifying in proceedings regarding the Company's past or future conduct, engaging in any future activities protected under the whistleblower statutes
    administered by any government agency (e.g., EEOC, NLRB, SEC, etc.) or receiving a monetary award from a government-administered whistleblower award program for providing information directly to a government agency.</div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-indent: 108pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The U.S. Defend Trade Secrets Act of 2016 ("DTSA") provides that an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret
    that (A) is made in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or
    other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, the DTSA provides that an individual who files a lawsuit for retaliation for reporting a suspected violation of law may disclose the trade secret to
    the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Non-Competition and Non-Solicitation</u>. See <u>Annex A</u> for the applicable non-competition and non-solicitation provisions.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Non-Disparagement</u>.&#160; The Executive shall not disparage the Company or their respective officers, directors, investors, employees, and affiliates or make any public statement
    reflecting negatively on the Company or their respective officers, directors, investors, employees, and affiliates, including (without limitation) any matters relating to the operation or management of the Company, irrespective of the truthfulness or
    falsity of such statement.&#160; Nothing in this Section shall prohibit the Executive from testifying truthfully in any forum or to any governmental agency.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Proprietary Information</u>.&#160; At all times the Executive shall hold in strictest confidence and will not disclose, use, lecture upon or publish any Proprietary Information (defined
    below) of the Company, except as such disclosure, use or publication may be required in connection with the Executive's work for the Company, or unless the Company expressly authorizes such disclosure in writing or it is required by law or in a
    judicial or administrative proceeding in which event the Executive shall promptly notify the Company of the required disclosure and assist the Company if a determination is made to resist the disclosure.&#160; For purposes of this Section 10(d),
    "Proprietary Information" shall mean any and all confidential and/or proprietary knowledge, data or information of the Company or its respective affiliated entities, including (without limitation) any information relating to financial matters,
    investments, budgets, business plans, marketing plans, personnel matters, business contacts, products, processes, know-how, designs, methods, improvements, discoveries, inventions, ideas, data, programs, and other works of authorship; provided, that it
    shall not include any information that is known to the Company to be publicly available.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Invention Assignment</u>.&#160; All inventions, innovations, improvements, developments, methods, designs, analyses, reports, and all similar or related information which relates to either
    the Company's actual or anticipated business, research and development or existing or future products or services and which are conceived, developed or made by Executive while employed by the Company (the "Work Product") belong to the Company and not
    to the Executive.&#160; The Executive shall promptly disclose such Work Product to the Board and perform all actions reasonably requested by the Board (whether during or after the Term of this Agreement) to establish and confirm such ownership (including,
    without limitation, assignments, consents, powers of attorneys and other instruments).</div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Return of Property</u><font style="font-weight: bold; font-variant: small-caps;">.</font>&#160; Upon the Executive's termination of employment with the Company for any reason, voluntarily or
    involuntarily, and at any earlier time the Company requests, the Executive will deliver to the person designated by the Company all originals and copies of all documents and property of the Company in the Executive's possession, under the Executive's
    control or to which the Executive may have access.&#160; The Executive will not reproduce or appropriate for the Executive's own use, or for the use of others, any property, Proprietary Information or Work Product.</div>
  <div>&#160;</div>
  <div style="text-indent: 72pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Injunctive Relief and Other Remedies with Respect to Covenants</u>. The Executive acknowledges and agrees that the covenants and obligations of the Executive set forth in this Section 10 relate to special,
    unique and extraordinary matters and that a violation of any of the terms of such covenants and obligations will cause the Company irreparable injury for which adequate remedies are not available at law. Therefore, the Executive agrees that the Company
    shall (i) be entitled to pursue an injunction, restraining order or such other equitable relief (without the requirement to post bond) restraining the Executive from committing any violation of the covenants and obligations contained in this Section 10
    and (ii) have no further obligation to make any payments to the Executive hereunder following any finding by a court or an arbitrator that the Executive has engaged in a material violation of the covenants and obligations contained in this Section 10.
    These remedies are cumulative and are in addition to any other rights and remedies the Company may have at law or in equity. The Company may withhold amounts otherwise payable to the Executive and recoup amounts previously paid to the Executive under
    this Agreement upon any violation of the provisions of this Section 10.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt;">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Obligations Upon Termination of Employment</u>.&#160; Upon and after the Executive's termination of employment with the Company and until such time as no obligations of the Executive to the
    Company hereunder exist, the Executive shall (i) provide a complete copy of this Agreement to any person, entity or association which the Executive proposes to be employed, affiliated, engaged, associated or to establish any business or remunerative
    relationship prior to the commencement of any such relationship, and (ii) shall notify the Company of the name and address of any such person, entity or association prior to the commencement of such relationship.</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Legal Fees and Expenses</u>. If the Executive asserts any claim in any contest (whether initiated by the Executive or by the Company) as to the validity, enforceability or interpretation of any provision of
    this Agreement, the Company shall pay the Executive's costs (or cause such costs to be paid) in so asserting, including, without limitation, reasonable attorneys' fees and expenses, if the Executive is the prevailing Party in such contest, as
    determined by the arbitrators selected pursuant to Section 16 hereof to resolve such contest or as determined pursuant to Section 10(g), as applicable. Any payment to Executive shall be made within thirty (30) days following the final decision rendered
    in such arbitration or other proceeding.</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;"><font style="font-weight: normal;">13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Non-Exclusivity of Rights; Resignation from Boards</u>.</font></div>
  <div style="font-weight: normal;">&#160;</div>
  <div style="text-indent: 72pt;"><font style="font-weight: normal;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Nothing in this Agreement shall prevent or limit the Executive's continuing or future participation in or rights under any benefit, bonus, incentive or other plan or program
      provided by the Company and for which the Executive may qualify; provided, however, that if the Executive becomes entitled to and receives the severance payments described in this Agreement, the Executive hereby waives the Executive's right to
      receive payments under any severance plan or similar program applicable to employees of the Company.</font></div>
  <div style="font-weight: bold;">&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-indent: 72pt;"><font style="font-weight: normal;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">&#160;<font style="font-weight: normal;">&#160;&#160;If the Executive's employment with the Company terminates for any reason, the Executive shall
        immediately resign from all boards of directors of the Company, any affiliates and any other entities for which the Executive serves as a representative of the Company and any committees thereof.</font></font></div>
  <div>&#160;</div>
  <div style="text-indent: 72pt;"><font style="font-weight: normal;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Executive agrees that the Executive will be subject to any compensation clawback, recoupment, and anti-hedging and pledging policies that may be applicable to the
      Executive as an employee of the Company, as in effect from time to time and as approved by the Board or a duly authorized committee thereof.</font></div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;"><font style="font-weight: normal;">14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Entire Agreement; Amendments</u>.</font></div>
  <div>&#160;</div>
  <div style="text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement and the other agreements referred to herein contain the entire agreement between the Parties hereto and supersede any and all prior agreements and understandings concerning the Executive's
    employment by the Company.</div>
  <div>&#160;</div>
  <div style="text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement shall not be terminated, altered or otherwise amended, except pursuant to an instrument in writing signed by each of the Parties hereto (including any successors and legal representatives).</div>
  <div>&#160;</div>
  <div style="text-indent: 36pt;">15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u><font style="font-weight: normal;">Notices</font></u><font style="font-weight: bold;">.&#160;</font><font style="font-weight: bold; text-transform: none;"> </font>All notices or other communications pursuant to
    this Agreement shall be in writing and shall be deemed to be sufficient if delivered personally, telecopied, sent by nationally recognized, overnight courier or mailed by registered or certified mail (return receipt requested), postage prepaid, to the
    Parties at the following addresses (or at such other address for a Party as shall be specified by like notice):</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if to the Company, to:</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt;">Westinghouse Air Brake Technologies Corporation</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt;">30 Isabella Street</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt;">Pittsburgh, Pennsylvania 15212</div>
  <div style="text-align: justify; margin-left: 144pt;">Attention: General Counsel</div>
  <div><br>
  </div>
  <div style="margin-left: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if to the Executive, to the address in the Company's personnel records.</div>
  <div>&#160;</div>
  <div style="text-align: justify;">All such notices and other communications shall be deemed to have been delivered and received (A) in the case of personal delivery, on the date of such delivery, (B) in the case of delivery by telecopy, on the date of
    such delivery, (C) in the case of delivery by nationally recognized, overnight courier, on the Business Day following dispatch, and (D) in the case of mailing, on the third Business Day following such mailing.&#160; As used herein, "Business Day" shall mean
    any day that is not a Saturday, Sunday or a day on which banking institutions in the Commonwealth of Pennsylvania are not required to be open.</div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-indent: 36pt;">16.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u><font style="font-weight: normal;">Arbitration</font></u><font style="font-weight: normal;">. Except to the extent provided in Section 10(g), any dispute or controversy arising under or in connection with
      this Agreement shall be resolved by binding arbitration. The arbitration shall be held in the City of Pittsburgh, Commonwealth of Pennsylvania, and except to the extent inconsistent with this Agreement, shall be conducted in accordance with the
      Expedited Employment Arbitration Rules of the American Arbitration Association then in effect at the time of the arbitration, and otherwise in accordance with principles which would be applied by a court of law or equity. The arbitrator shall be
      acceptable to both the Company and the Executive. If the parties cannot agree on an acceptable arbitrator, the dispute shall be heard by a panel of three arbitrators, one appointed by each of the parties and the third appointed by the other two
      arbitrators.</font><font style="font-weight: bold; color: rgb(0, 0, 255);">&#160;</font></div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 36pt;">17.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Miscellaneous Provisions</u>.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u><font style="font-weight: normal;">Descriptive Headings</font></u><font style="font-weight: bold; color: rgb(0, 0, 255);"><font style="font-weight: normal;">.</font>&#160; </font>Descriptive


    headings are for convenience only and shall not control or affect the meaning or construction of any provisions of this Agreement. When the context admits or requires, words used in the masculine gender shall be construed to include the feminine, the
    plural shall include the singular, and the singular shall include the plural.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u><font style="font-weight: normal;">Governing Law</font></u><font style="font-weight: normal; color: rgb(0, 0, 255);">.&#160; </font>This Agreement shall be governed by and construed and
    enforced in accordance with the laws of the Commonwealth of Pennsylvania applicable to contracts made and performed wholly therein without regard to rules governing conflicts of law.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u><font style="font-weight: normal;">Waiver of Breach</font></u><font style="font-weight: normal; color: rgb(0, 0, 255);"><font style="font-weight: normal;">.</font>&#160; </font>No delay or
    omission by a Party in exercising any right, remedy or power under this Agreement or existing at law or in equity shall be construed as a waiver thereof, and any such right, remedy or power may be exercised by such Party from time to time and as often
    as may be deemed expedient or necessary by such Party in its sole discretion.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u><font style="font-weight: normal;">Severability</font></u><font style="font-weight: normal; color: rgb(0, 0, 255);">.&#160; </font>In the event that any provision of this Agreement is
    determined to be partially or wholly invalid, illegal or unenforceable in any jurisdiction, then such provision shall, as to such jurisdiction, be modified or restricted to the extent necessary to make such provision valid, binding and enforceable, or
    if such provision cannot be modified or restricted, then such provision shall, as to such jurisdiction, be deemed to be excised from this Agreement; provided, however, that the binding effect and enforceability of the remaining provisions of this
    Agreement, to the extent the economic benefits conferred upon the Parties by virtue of this Agreement remain substantially unimpaired, shall not be affected or impaired in any manner, and any such invalidity, illegality or unenforceability with respect
    to such provisions shall not invalidate or render unenforceable such provision in any other jurisdiction.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u><font style="font-weight: normal;">Benefits of Agreement; Assignment</font></u><font style="font-weight: normal; color: rgb(0, 0, 255);">.&#160; </font>All of the terms and provisions of
    this Agreement shall be binding upon and inure to the benefit of and be enforceable by the respective heirs, executors, administrators, legal representatives, successors and assigns of the Parties hereto, except that the duties and responsibilities of
    the Executive under this Agreement are of a personal nature and shall not be assignable or delegable in whole or in part by the Executive.&#160; The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation,
    reorganization or otherwise) to all or substantially all of the business or assets of the Company, within fifteen (15) days of such succession, expressly to assume and agree to perform this Agreement in the same manner and to the same extent as the
    Company would be required to perform if no such succession had taken place<font style="font-weight: normal;"> and the Executive acknowledges that in such event the obligations of the Executive hereunder, including but not limited to those under
      Sections 9 or 10, will continue to apply in favor of the successor</font>.</div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: normal;"><u>Remedies</u></font><font style="font-weight: bold; color: rgb(0, 0, 255);"><font style="font-weight: normal;">.</font>&#160; </font>All remedies hereunder
    are cumulative, are in addition to any other remedies provided for by law and may, to the extent permitted by law, be exercised concurrently or separately, and the exercise of any one remedy shall not be deemed to be an election of such remedy or to
    preclude the exercise of any other remedy. The Executive acknowledges that in the event of a breach of any of the Executive's covenants contained in <font style="font-weight: normal;">Sections 9 or 10</font><font style="font-weight: bold;">,</font>
    the Company shall be entitled to immediate relief enjoining such violations in any court or before any judicial body having jurisdiction over such a claim.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Withholding</u>.&#160; All payments under this Agreement shall be made subject to applicable tax withholding, and the Company shall withhold from any payments under this Agreement all
    federal, state and local taxes as the Company is required to withhold pursuant to any law or governmental rule or regulation.&#160; The Executive shall bear all expense of, and be solely responsible for, all federal, state and local taxes due with respect
    to any payment received under this Agreement.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compliance with Section 409A of the Code</u>.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 108pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement is intended to comply with section 409A of the Code and its corresponding regulations, to the extent applicable.&#160; Severance
    benefits under this Agreement are intended to be exempt from section 409A of the Code under the "short term deferral" exemption under Treasury Regulations section 1.409A-1(b)(4), to the maximum extent applicable, and then under the "separation pay"
    exemption under Treasury Regulations section 1.409A-1(b)(9)(iii), to the maximum extent applicable.&#160; Notwithstanding anything in this Agreement to the contrary, payments may only be made under this Agreement upon an event and in a manner permitted by
    section 409A of the Code, to the extent applicable.&#160; As used in this Agreement, the term "termination of employment" shall mean the Executive's "separation from service" with the Company within the meaning of section 409A of the Code and the
    regulations promulgated thereunder.&#160; In no event may the Executive, directly or indirectly, designate the calendar year of a payment.&#160;&#160; For purposes of section 409A of the Code, each payment hereunder shall be treated as a separate payment and the
    right to a series of payments shall be treated as the right to a series of separate payments.&#160; All reimbursements and in-kind benefits provided under this Agreement shall be made or provided in accordance with the requirements of section 409A of the
    Code. <font style="color: rgb(0, 0, 0);">Notwithstanding any provision of this Agreement to the contrary, in no event shall the timing of the Executive's execution of the Release, directly or indirectly, result in the Executive designating the
      calendar year of payment, and if a payment that is subject to execution of the Release could be made in more than one taxable year, payment shall be made in the later taxable year.</font></div>
  <div>&#160;</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; text-indent: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding anything herein to the contrary, if, at the time of the Executive's termination of employment with the Company, the Company has securities which are publicly traded on an
    established securities market and the Executive is a "specified employee" (as such term is defined in section 409A of the Code) and it is necessary to postpone the commencement of any payments or benefits otherwise payable under this Agreement as a
    result of such termination of employment to prevent any accelerated or additional tax under section 409A of the Code, then the Company will postpone the commencement of the payment of any such payments or benefits hereunder (without any reduction in
    such payments or benefits ultimately paid or provided to the Executive) that are not otherwise paid within the "short-term deferral exception" under Treasury Regulations section 1.409A-1(b)(4), and the "separation pay exception" under Treasury&#160;
    Regulations section 1.409A-1(b)(9)(iii), until the first payroll date that occurs after the date that is six (6) months following the Executive's separation of service with the Company.&#160; If any payments are postponed due to such requirements, such
    postponed amounts will be paid in a lump sum to the Executive on the first payroll date that occurs after the date that is six (6) months following Executive's separation of service with the Company. If the Executive dies during the postponement period
    prior to the payment of postponed amount, the amounts withheld on account of section 409A of the Code shall be paid to the personal representative of the Executive's estate within sixty (60) days after the date of the Executive's death.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Full Settlement</u>.&#160; In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under
    any of the provisions of this Agreement and such amounts shall not be reduced as a result of a mitigation duty whether or not the Executive obtains other employment.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Government Agency Exception</u>. Nothing in this Agreement is intended to prohibit or restrict the Executive from: (i) making any disclosure of information required by process of law;
    (ii) providing information to, or testifying or otherwise assisting in any investigation or proceeding brought by, any federal or state regulatory or law enforcement agency or legislative body, or any self-regulatory organization; or (iii) filing,
    testifying, participating in, or otherwise assisting in a proceeding relating to an alleged violation of any federal, state, or municipal law relating to fraud or any rule or regulation of the Securities and Exchange Commission or any self-regulatory
    organization. In addition, this Agreement does not bar the Executive's right to file an administrative charge with the Equal Employment Opportunity Commission ("EEOC") and/or to participate in an investigation by the EEOC.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: normal;"><u>Survival</u></font><font style="font-weight: bold; color: rgb(0, 0, 255);"><font style="font-weight: normal;">.</font>&#160; </font>The respective rights
    and obligations of the Parties hereunder shall survive the termination of this Agreement to the extent necessary to the intended preservation of such rights and obligations.</div>
  <div>&#160;</div>
  <div style="text-align: justify; text-indent: 72pt;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: normal;"><u>Counterparts</u></font><font style="font-weight: bold; color: rgb(0, 0, 255);"><font style="font-weight: normal;">.</font>&#160; </font>This Agreement may
    be executed in any number of counterparts, and each such counterpart shall be deemed to be an original instrument, but all such counterparts together shall constitute but one agreement.&#160; This Agreement may be executed and delivered by facsimile.</div>
  <div>&#160;</div>
  <div style="text-align: center; font-style: italic; font-weight: bold;">[Signature Page Follows]</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date and year first above written.</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd0667e9eccc14be293d127a7d77282b3">

      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">
          <div style="text-align: justify; font-weight: bold;">WESTINGHOUSE AIR BRAKE</div>
          <div style="text-align: justify; font-weight: bold;"> TECHNOLOGIES CORPORATION</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5997b0d7c36d4149988728bb9951d959">

      <tr>
        <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
          <div style="text-align: justify;">By:</div>
        </td>
        <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"></td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9ae7d0daa8e44e6aaefd08b53ba1c808">

      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">
          <div style="text-align: justify;">Name:</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">
          <div style="text-align: justify;">Title:</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf8ab53a2bc0b4d509fb63871d3c3498a">

      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">
          <div style="text-align: justify; font-weight: bold;">EXECUTIVE</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"></td>
      </tr>

  </table>
  <div><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center; font-weight: bold;"><u>Annex A</u></div>
  <div style="text-align: center; font-weight: bold;"><u>Restrictive Covenants</u></div>
  <div><br>
  </div>
  <div style="text-align: center; font-weight: bold;">(U.S. Employees)</div>
  <div><br>
  </div>
  <div style="text-indent: 36pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Non-Competition</u>.&#160; Because of the Company's legitimate business interest and the valuable consideration offered to the Executive to which Executive would not otherwise be entitled, including as described
    in Section 4 and 8, and except where prohibited by state or local law, the Executive covenants and agrees that during the Executive's period of employment with the Company and for a period of one (1) year after Executive ceases to be employed by the
    Company, the Executive will not directly or indirectly, on the Executive's own behalf or on behalf of or in conjunction with any person, business, firm, company, or other entity, set up, join, become employed by, be engaged in, or provide any advice or
    services to, any enterprise which develops, produces, markets, sells or services any product or service which is the same as or similar to products or services manufactured and sold by the business or function the Executive worked for in the last two
    years of employment with the Company. This covenant is limited to any state in the United States of America and country in which the Company is or has been doing business during the twelve (12) months prior to the Executive's date of termination. This
    covenant does not prohibit the Executive from purchasing or owning less than five percent (5%) of the publicly traded securities of any corporation, provided that the Executive's ownership represents a passive investment and that the Executive is not a
    controlling person of, or a member of a group that controls, the corporation. The Executive acknowledges that as an executive, the Executive has access to Company-wide confidential strategic information and customer information for the Executive's
    business or function, that disclosure of that information to a competitor or use of that information by a competitor would cause the Company irreparable harm, that this covenant is reasonably necessary to protect that information, and that the
    Executive has received sufficient consideration for the covenants contained herein. The Executive agrees that a court may modify any provision herein that it deems unreasonable or unenforceable, and the remainder shall remain in full force and effect.
    The Executive acknowledges that, if required by applicable law, the Company advised the Executive to consult with an attorney before agreeing to this covenant and provided the Executive with at least 14 days to review and consider this covenant before
    agreeing to it.</div>
  <div><br>
  </div>
  <div style="text-indent: 18pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Non-Solicitation</u>.&#160; Because of the Company's legitimate business interest and the valuable consideration offered to the Executive to which the Executive would not otherwise be entitled, including as
    described in Section 4 and 8, and except where prohibited by state or local law, the Executive covenants and agrees that for a period of one (1) year after the Executive ceases to be employed by the Company, the Executive will not, for his or herself,
    as an agent or employee, or on behalf of any person, association, partnership, corporation or other entity, directly or indirectly, solicit the business, or aid to assist anyone else in the solicitation of business from, any customer or prospective
    customer of the Company or supplier of parts used in the manufacturing of products by the Company with whom the Executive had direct or indirect contact or about whom the Executive may have acquired any knowledge while employed by or through the
    Executive's employment with the Company. The Executive also agrees that, during the Executive's employment with the Company and for one (1) year after the Executive ceases to be employed by the Company, the Executive will not, directly or indirectly:
    solicit or induce, or attempt to solicit or induce, any employee of the Company to leave the Company for any reason whatsoever, or hire or participate in the hiring or interviewing of any employee of the Company; or provide names or other information
    about the Company's employees for the purpose of assisting others to hire or interview such employees. For purposes of this paragraph, a Company employee means any person who is a then-current Company employee or was employed by the Company within the
    six (6) months preceding any alleged solicitation of any action by the Executive that violates this covenant. The Executive acknowledges that this covenant is reasonable, and that the Executive has received sufficient consideration for the covenants
    contained herein. The Executive agrees that a court may modify any provision herein that it deems unreasonable or unenforceable, and the remainder shall remain in full force and effect. The Executive acknowledges that, if required by applicable law,
    the Company advised the Executive to consult with an attorney before agreeing to this covenant and provided the Executive with at least 14 days to review and consider this covenant before agreeing to it.</div>
  <div><br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center; font-weight: bold;"><u>Restrictive Covenants</u></div>
  <div><br>
  </div>
  <div style="text-align: center; font-weight: bold;">(French Employees)</div>
  <div><br>
  </div>
  <div style="text-indent: 36pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Non-Competition</u>.&#160; Except where prohibited by state or local law, the Executive covenants and agrees that during the Executive's period of employment with the Company and for a period of one (1) year
    after the Executive ceases to be employed by the Company, the Executive will not directly or indirectly, on the Executive's own behalf or on behalf of or in conjunction with any person, business, association, partnership, firm, company, or other
    entity, set up, join, become employed by, be engaged in, or provide any advice or services to, any enterprise which develops, produces, markets, sells or services any product or service which is the same as or similar to products or services
    manufactured and sold by the business or function the Executive worked for in the last two years of the Executive's employment, or directly or indirectly, solicit the business, or aid or assist anyone else in the solicitation of business from, any
    customer or prospective customer of the Company or supplier of parts used in the manufacturing of products by the Company with whom the Executive had direct or indirect contact or about whom the Executive may have acquired any knowledge while employed
    by the Company. This covenant is limited to the European Union, Switzerland and the United Kingdom. During this period of non-competition, the Executive will receive a monthly gross indemnity corresponding to 50% of the average gross monthly salary
    received over the last twelve (12) months of employment with the Company, increased to 60% of the average monthly salary if the Executive is dismissed by the Company and until the Executive finds new employment, which shall be reduced by any severance
    payments Executive may receive pursuant to the terms of the Agreement, within the limits of the non-competition period. The Executive acknowledges that this covenant is reasonable, and that the Executive has received sufficient consideration for the
    covenants contained herein. The Executive agrees that a court may modify any provision herein that it deems unreasonable or unenforceable, and the remainder shall remain in full force and effect. In any case, the Company shall be entitled to waive this
    obligation, provided however that it informs the Executive in writing within the eight (8)-day period following the notification of the termination of the Agreement.</div>
  <div><br>
  </div>
  <div style="text-indent: 18pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Non-Solicitation of Employees</u>.&#160; The Executive also agrees that, during the Executive's period of employment with the Company and for one (1) year after the Executive ceases to be employed by the Company,
    the Executive will not, directly or indirectly: solicit or induce, or attempt to solicit or induce, any employee of the Company to leave the Company for any reason whatsoever, or hire or participate in the hiring or interviewing of any employee of the
    Company; or provide names or other information about the Company's employees for the purpose of assisting others to hire or interview such employees. For purposes of this paragraph, a Company employee means any person who is a then-current Company
    employee or was employed by Company within six (6) months of any action by the Executive that violates this covenant. The Executive acknowledges that this covenant is reasonable, and that the Executive has received sufficient consideration for the
    covenants contained herein. The Executive agrees that a court may modify any provision herein that it deems unreasonable or unenforceable, and the remainder shall remain in full force and effect.</div>
  <div><br>
  </div>
  <div><br>
  </div>
  <div style="text-align: center;"><font style="font-size: 8pt;">17</font><br>
  </div>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>wab-20221205.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.2.5096 Broadridge-->
<xs:schema targetNamespace="http://wabtec.com/20221205" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:wab="http://wabtec.com/20221205" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="wab-20221205_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="wab-20221205_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://wabtec.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>wab-20221205_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.2.5096 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>wab-20221205_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.2.5096 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://wabtec.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="wab-20221205.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://wabtec.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140529788612096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 05, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec.  05,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">033-90866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000943452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">25-1615902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">30 Isabella Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Pittsburgh<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">15212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">825-1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WAB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>brhc10045145_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="wab-20221205.xsd" xlink:type="simple"/>
    <context id="c20221205to20221205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943452</identifier>
        </entity>
        <period>
            <startDate>2022-12-05</startDate>
            <endDate>2022-12-05</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20221205to20221205"
      id="Fact_e5debd7f500b4f519f12a7d42d1fbb75">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20221205to20221205"
      id="Fact_e342fe88c58b4c16a6eef6199963f458">0000943452</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20221205to20221205"
      id="Fact_3fd2021ee04b49aea9ae5191fd393f25">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20221205to20221205"
      id="Fact_e2e87860617046b78ae53006ac5f0d39">2022-12-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20221205to20221205"
      id="Fact_b11d91a35dc64fe7bd1c9450c0b8f4f1">WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20221205to20221205"
      id="Fact_501798fcd172483e9fc6c3e52fc61135">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20221205to20221205"
      id="Fact_d5a59d4d309a474090dd6fae08ceb614">033-90866</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20221205to20221205"
      id="Fact_f33ebe0a75cf4d68872ed939d9c977e8">25-1615902</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20221205to20221205"
      id="Fact_3f47c301fb7b4c53a1492e2c35ec6657">30 Isabella Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20221205to20221205"
      id="Fact_67a03bae88204533875e17b7b3870419">Pittsburgh</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20221205to20221205"
      id="Fact_7541b58130e64e4ca1c6e8a772b55a1a">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20221205to20221205"
      id="Fact_db6b7ff4a5d54eb19b9a55b6fa54add0">15212</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20221205to20221205"
      id="Fact_7048686b9930451997f00c04e6e9321c">412</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20221205to20221205"
      id="Fact_127f67272bca4be183cee38f8a8c7487">825-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20221205to20221205"
      id="Fact_de39523dde3f4d9a986e2473e8c36b98">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20221205to20221205"
      id="Fact_bfd4a6e90ae34489b0cfebdea18f408b">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20221205to20221205"
      id="Fact_02c695b5f6f44a27a30a46b48dfb56fa">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20221205to20221205"
      id="Fact_99f29e6b20374b7495a483ae2ea099df">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20221205to20221205"
      id="Fact_fa81869646b84ceb8620fafd35961c38">Common stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20221205to20221205"
      id="Fact_b371d0a19b5f4b62a952d9aebf618bab">WAB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20221205to20221205"
      id="Fact_9b78b14375cf4f32bb7fab435be0738a">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20221205to20221205"
      id="Fact_a3a869b587fc4edc9f1e73c1be51212f">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M:%8KF+J^52GU6<^"PE5,;IG5_^4GM^W\CO U"KX&IEXF</F1LBHX/+QS^8Q
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M/UY_ 5!+ 0(4 Q0    ( %U2AU4'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 75*'5>^.#X/O
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ 75*'59E<G",0!@  G"<  !,              ( !S0$  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " !=4H=5R@;3]6H$  "O$   &
M            @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ 75*'59^@&_"Q @  X@P   T              ( !K@P  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " !=4H=5EXJ[',     3 @  "P
M    @ &*#P  7W)E;',O+G)E;'-02P$"% ,4    " !=4H=5'#AEZC\!   \
M @  #P              @ %S$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ 75*'520>FZ*M    ^ $  !H              ( !WQ$  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 75*'5660>9(9 0  SP,
M !,              ( !Q!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @  #A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10045145_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://wabtec.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc10045145_8k.htm">brhc10045145_8k.htm</File>
    <File>brhc10045145_ex10-1.htm</File>
    <File>brhc10045145_ex10-2.htm</File>
    <File>wab-20221205.xsd</File>
    <File>wab-20221205_lab.xml</File>
    <File>wab-20221205_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10045145_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "brhc10045145_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "wab-20221205_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "wab-20221205_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "wab-20221205.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "wab",
   "nsuri": "http://wabtec.com/20221205",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10045145_8k.htm",
      "contextRef": "c20221205to20221205",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://wabtec.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10045145_8k.htm",
      "contextRef": "c20221205to20221205",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://wabtec.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001140361-22-044669-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-044669-xbrl.zip
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ML ,1/YNR=;S&<5(.6TLYXCBVS0-JZ!?"[VYV/W(3NWD(E),I:$T3R45C!B,
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MYW]Q?0D]A;Y?XLFO^>2)"GY'(?<7VOE#1PT0KYJ 1@2LXH;KC/-U8.R"T))
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M\KFRETXG64.'LE>B ZH#H+XBP7B="Y4<V#^ED*7CWDQ[ ,6<RJL9#<QE7'+
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M(Y@6TZ7%34]<N[N<JCXNV,\ND'RKQ0-"O\7SD4VP:'(:7%*;.SL[@=PKSUC
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M/4\S-A#KJ?@[I* C^=VIF&[AMFD_R?@ ?;2=\X1Q0NHZ?%!)(45LRT'^#JA
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M DF+WR+$Z?+FP5'W. 3=+/).SJ-G2?1%:+VB>/H+/<1\UIEP0:XN-GY[M).
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ML>,FN[#)6[B(\/1HE9@B34:VN;2V2'ZU,.-B.BN7M4V.LPKNF/EDDW,[GA5
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M@9<E*U!0P5"\Q:.R ':Q,"LS GWH,FN0']8+O/O(W.&Y25:/X;D53"NYG&7
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M>%%9>2,\E@TD,O5PR!QDA<P)7M-XA+E_N 2&4\^R!:TLM<PDT?H@.^AT"5;
MX8-T[X$RC'@I*>D\.;T/CD;^&I*)%93L6!\2XP9)@<2";"HPSP<'WQ'+AU6Y
M9_Y1DJ#X6%[">^-Q7FQ/.[<EGF,F![)3<Q3V=)B/#K_S(!8!IW[EK"/NV,_C
M?$E2_<*,#:+5UC1XE'2+1I;N%8AA_(77)E%@W\%*;[Y4O!N(VBWG<Z^E&%A9
M-;75D+X!I2,5#!>6 (=FQ9I"PKC(ZHPM<# V+/XOTSVH8HNRSOR(-3# #HD0
M5BM:%WP5!&'=E.-/LS)/;4?/3K(Y2+D,6!!*/6?U(XD)\%29HC:L??*.H[#$
ML=;3L1XR<#!&#]1PL"WFM[(B;:1+MP0V(WN(!3,M!\Q,A#H79<6,@SB+78$8
MRM-X$?J%=,%VCG<=Q#9&FTX=#RR#U]PZ)4:!JXN,E&?24)TJ-M:(_,[KGJ';
M1TPV)7&4UO.D8;[I&4$3A=F$+(8)@?E^RD,U8=+N^]Y.Q#(42Z'W_ C\T+N)
M1% SWZ&;3(R(#S+L($(ZO<3:2W>M=VRB:+UZ7S:H22.-I&Z>H+O9:4EKSR9!
M?<MP$XD7H]D$,F+%2G@MD.[#@V?'89XI'Q>KO!HJ7ABV'QSJ,P?=IA'0"9]L
M2_PAW)GNIX&!I8@-L=,%$662\96#L6!C2?;#KVJPYD:T##FGQLYK,A'WG*4T
M*F& 92'LU<JCE^42+H;):[(601UJEJ!R@'7HYU1Z809K#1#F6*8J=J=^ D=7
M3TU$<GIUG^^FVTU/ ['K@27CNNV_'PQ@>N<:'PKCK$P%Z%[W=4?O6]#'2(A
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MZ?KC#W'K8YS 0@ S#\^[(*DK GPI+-V%QZ.3H4L)ZS?L7K3P8ELM_.^@Q<R
MD;UV4:YORKIQQGC_EZVX,^>*L/^#=F!\*__S+T^/#I^\J-O(_%P&IJR"Y1SV
MM&Z"0S;%:!O44S">B%UR(O6RHEY6*)2<.0KZ(L5V*>H3WE)WE.2>>,F- N*^
MX62#5P^^X60WOYSEMI?S8U7NG1*2>\P1P:\Q74 N9_^7:V.)*=% KFI\+3S
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MBQ*(5O^<)*S!I_> /QGM"Z<3::]0ZN[@,N4J8YFJ6EQ"/N.O%=DJ14&<&H'
M,O,[MT]@<EA5\.J'DIA4-<8HP=P.G<%".:!HN8]LRUW7\N%?</%(%\9"&XBI
MZS8WBSIR=O7+1(\/C81W>DQ ^& '$[),FN%$7I!B=(.MO7I738,Q4HX7:(<C
M*$T4@2<SYEIIT57:N=.MDAT(^[6K]@M'"R>CIZD\@+HJF/J%S* ?>.O6%V,=
MT-&_1>KGI$$'9KN!]W@^=&->4$HQLXDIYR^+!P(-7U(Z:[X3K-D._1XA),@[
M%_P)5QRC4W*,PV$7+HZ6_\8<"SO.6.1Q0>%@$0?2=[@D,@-3@;Y%XG[G\Z[P
MAT4F.'%4DF[C5P:W2XMZ*=MDQ6^A7 ^=1.DW8,T%DCIV;_GQ91%OGP.QUVS<
MYF<3-DQJXUDXWDT2I#]>88QX71/]H>U(-%7L\B&F\?@)J/0/0NLYOYJ+K/:C
MAD]V9KL$^H3+P$@*76'RO];[R8<U E$*AU!2S5J1Z*69R$.Q"D4HKIM[Q-/6
M"YR;N\SOO$9?Y!UO)[T#A6'0W=35'9754?XV53+19FPP,6$_2L:L>$?G6'-8
M0@Q43<>("KH^ <DWQT3T2*5X? !4T-'\^%RTR.PKF;?CXAFDT $9OK5(PY#1
M#_I-;BZ!M/J 1(<6LH0+Y3_#*2.\*,$DPHY)%B"?"5$<-(W'!WNX$OF5@T?#
M6PFH]+^6%X?(S)A6>0L\R(F LZ]!UAK2"I+HEU(XLT:.B&JF^<*8H:8 .7F8
MW46'U54E8W=:#Y;Y+>IN\.K1-T2RE[V)]^;1]E6:#<6+I4DK$6_-%;K&E\$A
MX'U8@4^YT3DYS:Q=%KQ['_&-%'C.*:5*CO5A^WR\#N!7=NV:.R;(77\DX="7
M)?X&H6P(H3BZ6:]2;*L1K$=YQ<9P!92<-<HOY-0@RXBALT;Z"A:K)4DR62_I
MJMF;%#VL/B;_5N;()"3MSB+E*S9UKK?/[L5)_'A;-M.IWWHKW[YVY>.&29:?
M)U:^"#=P %[/'V2^3%/W1]2W5G/E@)YL>T#_*'.P 1'.BGSV04=I^9U9'3YO
M!SL,XZ"*=?$4_9$4GK==R&2R7!,&ZE,E=8)H9\%P&6>6/,TL8H&1J_QW()2O
MB48VN=E/[S/\HZ^@T-?9/Z%OIG*@:TV^EJWG>WQDD^[2?5;=C>,O-@B]8')_
M^B\4?_%G<LXCXXN)A8JKPN^P1E';:4JH5C??[+),=H[$Z]PU]+6_DV+4],^O
M]:K_ZSFN^X]D:P>VB*5+>':U-RF7%1S"PR]40.";V_C+N(W_K#C-XV\XS9\F
M,J"/_=U!A(#+X?A*PP3Z5OT[^\F'['<"A:G?:Q4%%[3$_/H(@[8J&ER_V_G3
M01L%U;0B9$Y\ZPBNK&[J8=_P+#K><J&G=AC]5=YR+A:]X0;?W=YN[%67;=2O
M<YN)54NHB8SYG,V7<UZ\'LHUA+DBJN"&%J?X;][LWK4+NG^3;^28#B4WOI!W
M^BK']#UZAYU=]O0.',/W[ CN^(!]A;!OCN!;.H*??KV.X'6HQOT[@WN\MQV'
ML/BQVC+S3^D*[H/YGFT+\SD*/'IZ\'/D'Y32Z1=>.5Q3W-Z5M(]+S^-PP<S#
MRO_9!"L^J1K]/AC;-[;QNB@U8FBJ;+34%?" @*4 6%3K;D?J(WDR<-5$RTDT
M'6 4B(VH2>V2<1K*([GF-FW3%FMF62&,C*I2._>AGJE-HS_9(;1A%JA+=[_$
M]H0[U"!ZQ5VQAU+#1/<9*)(!*K U=E>M0(+#AZ(VR%-)V))UNQ$?#O%HGQ A
M<?7)A<F77F_[Z.Z$*DK;2ILE_I$NQ[ 3.VC2,R,$!I7\TU;EKMN$4_G-L=0I
M2+&A,+(<_.DNP:P$2&!3,@_+XT]Q&3]EU1P?<<D>_) $@#B:<HV19E;54<1.
M<[XZ6WQ/N;8*2$",M@6SU$H<V5YC/GNJH&O,AU&48=P )ZMW^?V8@U6K^T>H
MZ=!(;CXWFXMVMKE%,S_AC5#<R=WO>$;WU6-Z6]P>%S2(Z6,0IJX TL](H]+O
M*B97UM1)FP83N;Z.M#MD'=U+GU1OEK5H ^X)]0!O>B0'NKK;R><Q7NYS.,46
MQ0^ORTS13"S=W7D8ET!6M$"=P ;A30.Z_=*YA#]%*LKFV'HE;7<+>?;L68LK
ME%-F>[[V$+:CK- ((G=X87*N[LOCJ;HMJ@0,B>OP\F^Q3X-73[YA:K]W3^:K
MKWE'?)&7L\!X<5<!"^T>L/RI8+P$<U %:T,^-[B[Q&Y:/%Y$,+:1*>?96+B.
MM.IDS*BE,NXGOZ*A$6JYAE1$IQW-!&LAJ)Y'9 4&YB9=E5S!@I7 \#[6*<TF
M$Q@>>12ZB(;\(Y*,[=6#9$HH\8!6[;W@*)69"8?>[IOM::P+!='T-3:W/H:I
MQX)5F+K(\VO$*]9$H58$=F%I7@F/0K6S*R"':0'$DKK"2=2$%O4:4J>5:DN-
M[_*&F_1AW95N80$*<\--)S/3^Z(V0[E8I8>]VXM4^CVGT^ON<ERHI*6)#7:U
M^&FK:;PI3L7A3B[1GM+D*3B*ZE53#S63CY>Y?(],I%T,MUN+0Y3=PP,N(5>J
MLJVZ]YE,]-@%8T5S<=O:OP0XUU'&>$#H2K9N/GV14-U)N_HQY8*05DI:]BWJ
M%B4"TE@5^QJCJUN>!WXYQ="8B8%=X8UP%8% BE ?(?;!$==J,LF 7B7:$$3]
MJL3:8>UJ\\ANXEJ!94$4VSB' -B+A+<*2.RQ9'FFOU[Y$*<&BM8T3@\?FP)-
MB.G2(#2U4G%T82' X2K<(N+NLO/"SP1'OC!9[HPUW9JD?8B%-%B)SZF(6UD'
M@HC@'5(0I!B:GZ2:V'Z"',551;02%0*[##L0_*%MXLM\"I1WY<3WI[+ S:7G
M<RO#1# Y3[YE!2*D+G.J^'^/-?,$ES@\V!:8.+5H2+-7YXTCJZ^@" SW^)EP
M^3RXH>\*0NIO'0=U#[V$VUR&VD&@80%2!F0QMN)-?+?S->"'OQE<PZSBPH!C
MO?(LK'RH^A27!"J:3E\<W128.S)'U2.I<1_\0+K,$[_,*A?V3>8$E3B4SO;X
M*W2J<?%WV^-V4"&ZF_6NNWYB/G4,V5( ;!9+X 5CM06Z<444/ ]_+PMI[L$*
M0-.9^"XPBTF(?=BX$U^W8&:?Q(&9QUUDXA)8TD>F$Z$A$ 8Q[3QO:7/&U1EG
MG+!<5JJ*Y*A,5U@6'L_B-SB2.LVD?!VZ'8E3<H70(95=6Q98C=;ZWK%P79;Y
MU :V>@W5,0>F)CHQ^!J+8E2253<Y.(/LYE4=[RX@ZGT9BM&60$N^!;"TL@JN
MJY%M+JV]1@5)=K38CMJ:>*6L+U26&D2POA9U&V(:61/4JP[$YVE,\7#9,>I:
MV>#U01"&'9:@7M09->N#C_+D(BMS%V>X,!@(D2V8>62H1U-8?PA$M"1XY%NJ
MKF9Q4#V^FB$V$#(,64R6A"!C(O 2*_3;8FJF,@YNI'R/"N,%SQA&;UCO#K#G
M)>QHD]M13NW J2U/XZ+S3(JF8-U8\:'@J'HSIK: P]VQ^]/]87)R\N'-,'G_
MM]/7P^3L!/YIF_'^+K?2P4!*KODU!V*F &[VG-$9&37H7O3.>'+\""QB6IDY
M)S&XTXW.S7>>QNO3G? WT&;PZNDWT.9^NKO_LG^VG[P%31:XV'F%YO,9Z1LU
M-KU#D7)T</@XV1F\/3\['NRJ'@CL-M)L,O*_4C#"N,I0?.;<5'T,/\1_@EP/
MN 5=?(L54W/79HL,Q]0ZQ2<WEUY-0D0H)]N(I9W^H8]6;+@M>LUH0%9XO8G9
MIW'O&R:2  >#8W^=7%\]ZLF3X8_$,%G7'I[M>4/A**CFKURT>,X-QWGB#AHJ
ML7^WL[9I),]=B=W42]*U;!J8,CX#>_""XB9>1PLS'&X.*ECC1;8XELOQDA,Y
MLEQP;1RD7F9*.0C,FQR$4G"=ZN&ZESB0VN3[Z)1TH>JLW2!-7$D1V#MR0LV/
MPMLGQ& ;DV>A*F78DJMV@+SD0@'6 0R!3IST(Y>#G(73I+0PA\-9]CVO.;)K
M6T_*5&N;6N/)^J@[C>PYX@-P)JK-?'A+V- X-6'MNGRXG-;YG)8'8]T/@+=U
M6,?[LMA[H[ )7"Q^=H8*5M:H5MAGUB;PP'%1V,_),34N=K=&A3-@)?)Q:SRJ
M3J[&4\D67R.L*;OR-JO1<<S81#MYK\=@0-+@!]KV$MEHVCSC1F*8$.,K1 ^%
MQ= _I:.#L_%"[P#J>>F#9-B@(N88.@)4=D*EKX&H78N*W'>[O9=):?C+%]C.
M0:(TOG+-RO<W:-N[C.Q)D-K<%++?'=,JJZ*IRO4#K7FRS-'2]7QU8O(:+?80
M""?;HS*:9J+-]H#30)JS;)3UZOQ*I7:O1N^[:,5EM9Q[*:/U6;),;JH@;D[L
MZ1TTF0'3A;7G-D[CX."&2]53QDR?P>S $T:CT/>IA#EW4PFWA!CH,*'L5:15
M5!,(,4;-&XFZ9C_JFHEYSS ?N 1$M E&N#$6Z"<<VVLD]&+_*@F]:@=VL382
MM3IN@PJ79?7)<T#_6OA;!3*X^R:>>/0*.5BC,R_*P$ 34#0.*=\819JQ*N*Z
MC?X&=PYU'\)DQ+RIC$0C.EFX2=HG_'J^0)T)C==)"^^1VOAN(FK"Q 9J;%@;
M/4$9@+'?P*DIE/WF'PA#.3K[B8Z%5+ 0 !22\8#6A[STP1K::+4F4RU:-"8G
ML/M"C>$QDB$C)+31@>1:>!^=3ZVYIP+"*-<OVY OZI=HW@@$;@HZ7.&<LG!F
MR 278T803)C_P7@?M>V O\$@^F2YXAA_ %RV1GH.PX5G2 T:XS"P(6CR\[_&
M@A_BSNS-, >2H2 <WL)B4ES@G#P%,AT\3^1ZLG8D-\8B8.--S1L[=':VB!'6
M</$N<>,%NA[HP-&%#CC(NM%H/;(25]2@O8\N)AMGWFD3R1Y*OOMX'YWCXWZ8
ML]V6.;]SVY@<^Y;1$6>FX@YJJXNBO' 84.MXL*5-N9"__!GZ4P7AFZ_HR%G/
M=X(>L6WI9$PV0"[%%L.&,W_A;\AGQK98T/-5OQG?+1[;)!. A=Q-:)&Z/%O*
M82.M.\PXH5R*K';L44 H1[%DDW*F!N///"7#.!;EVZ9^!S@&T?F@E8MT!C9"
M:*?5 K[9M?LK<OV/_%:PLU'X=,%[5GJ=I=L.7KA"C?2,V)L9)"3T2]UXU%^,
MWB3>KX2S4IS/2YJ1KHAS<Q:%J_]+3^ZX:$WQ /C"GO@33.KH!F!2;")6HW$B
M.F6V6DDCZ^!\#<CJ,,0[Q>QOJ'J@UT,'J2/K04R.F8%8A[7B%-A@JR+SK;Y1
M1X@_*^#V[!O@=G.N/-D^&0*X#VD%J(?8BJM&=8_4'>$(U&,YP M3908G0UF)
M>V.S@+- AR@=H_"&7_IRTM8GXG9*QL=E0>*2(LY0 JD1/A56SQ'F+M>(LMWT
ML,)*.F4.2+F7@"W?SX4TCI;[J.TS!4UXBL"C*SVZD Y0^)V#:?B[A>QS6Q/K
M:5Z,7A.0)<1C@C]"_<('?'!T"$VY)_>9C )NU4P=L?L9MS=LL-(Z<N@00@'*
M):*DSD:(&I*#8D+VCPJL7S+N2'R.9._*KWJXUA:"9[5TV-KM/]U>8?EM6;!.
M? H483E.G7O8G%H,L<).9TBPIR'\-0Y=:.TP\ >GG-<ADDM%KT?Q-"[D1%>P
M56)V;:W1PP-18"@<%SOLF7SH L4SH'L)1@$+B]()\2!\T\;"Y6?$8*BRGWQ.
M TG*]3,F<AH;AWQZ,J\J:AZ&$%L&.RQ=)43+2;$60X-&FNPOZCU(DR&LQQ!
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M>=>K%>NB.7&KWMK:3ZY(1>#=>+ZNP*5DE_(Q43$<PJVE6[)26-M]T*\JLJC
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M@2FN:2@!%H-/NS\@ Z2_M18^ 0S_(M88XB9O<#*FJ4NNKD87LN+\MCB0"P>
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M.$*!<@DJ-'VH%?O>DE=M E0;8))<$Q;?KFKA;+%@#";%?U=AC"=@)5AT4AV
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M+FAT;5!+ 0(4 Q0    ( %U2AU7N5?>(0P,  #$/   0              "
M 3O.  !W86(M,C R,C$R,#4N>'-D4$L! A0#%     @ 75*'5:VQV)E_"
M=5@  !0              ( !K-$  '=A8BTR,#(R,3(P-5]L86(N>&UL4$L!
M A0#%     @ 75*'57\)#KW7!0  [3X  !0              ( !7=H  '=A
H8BTR,#(R,3(P-5]P<F4N>&UL4$L%!@     &  8 C0$  &;@      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
